Culturing Rat Cortical Stem Cells Expansion using the Neurosphere System
常春藤皂苷元通过调控巨噬细胞Mincle介导的炎症减轻银屑病小鼠皮肤损伤的作用机制
◇基础研究◇摘要目的:观察常春藤皂苷元(hederagenin ,HDG )改善银屑病小鼠皮肤损伤和炎症的作用与机制。
方法:通过在C57小鼠背部祛毛并连续涂抹咪喹莫特7d 建立小鼠银屑病动物模型,造模后1h 给予HDG 灌胃治疗。
总计设置正常组、模型组、模型+HDG 低剂量(25mg ·kg -1·d -1)、模型+HDG 高剂量(50mg ·kg -1·d -1)和模型+卤米松阳性对照组(每组8只小鼠)。
给药7d 后,对患处皮肤进行病理检测,以及炎症指标进行ELISA 、实时定量PCR 检测,Mincle 及其下游信号进行免疫组织化学、免疫荧光和Western blot 检测。
结果:与模型组比较,HDG 干预组皮肤病理损伤以及炎性细胞浸润均得到不同程度改善;实时定量PCR 和皮肤组织悬液ELISA 结果证实HDG 干预后小鼠皮肤中炎症因子IL-1β、IL-6和TNF-α的mRNA 及蛋白水平均比模型组降低(P <0.01),说明HDG 具有显著抗炎症作用;免疫组织化学和Western blot 结果表明,与正常组相比,模型组小鼠皮肤中Min-cle 的蛋白表达量显著增加(P <0.01),给予HDG 干预后明显下调(P <0.01);免疫荧光证实模型组皮肤中Mincle 表达与巨噬细胞标志物F4/80共定位;Western blot 实验发现,HDG 在治疗组中不仅下调了Mincle 的蛋白表达,同时也下调了Mincle 下游信号Syk 和NF-κB 的蛋白磷酸化水平。
结论:HDG 可显著改善银屑病小鼠皮肤损伤和巨噬细胞相关炎症,其潜在分子机制可能与下调Min-cle/Syk/NF-κB 信号途径相关。
关键词常春藤皂苷元;Mincle ;皮肤损伤;炎症;银屑病中图分类号:R965.2文献标志码:A文章编号:1009-2501(2023)12-1339-08doi :10.12092/j.issn.1009-2501.2023.12.003银屑病是一种慢性丘疹鳞状皮肤病,其主要特点是遗传性和复发性,还可能并发其他疾病,如心血管疾病、糖尿病和关节炎等[1-4]。
运动系统词根词缀总结(共3篇)
运动系统词根词缀总结第1篇dystonia 肌张力障碍cartilage 软骨tendon 腱Ligament 韧带articulate 用关节连接起来的sesamoid 籽骨,籽骨的diaphysis 骨干epiphysis 骨骺metacarpal 掌部的metatarsal 跖骨的phalanx 指骨,趾骨heel 跟骨ankle 踝骨fracture 骨折humerus 肱骨,肱上膊femur 股骨cranial 头盖的,颅骨的strenum 胸骨rib 肋骨thorax 胸,胸廓scapula 肩胛骨vertebra 椎骨,脊椎fibril 小纤维,原纤维fascia 筋膜flat bone 扁骨irregular 不规则骨spongy bone 松质骨striated muscle 横纹肌smooth muscle 平滑肌visceral muscle 脏肌secretory duct 分泌管运动系统词根词缀总结第2篇向下下降 down一边离开away away from完全的 thoroughly completely entirely 去掉 off分开apart十人民牙齿皮肤右二、使…变成,分开,离开,两个,双日二du=two二Dict- 说否定,发散给教人民、家给睡眠跑引导力量坏,不良endo- 内部后面Epidemic /,ɛpɪ'dɛmɪk/ n. (疾病的)流行,传染Epilogue /'ɛpɪlɔɡ/ n. 结语,尾声Epitaph /'ɛpɪtæf/ n. 碑文,墓志铭equal /'ikwəl/ adj. 平等的equation /ɪ'kweʒn/ n. 等式equator /ɪ'kwetɚ/ n. 赤道equanimity /,ɛkwə'nɪməti/ n. 平静,镇定equ=equal等,均,平equal [equ相等,-al形容词后缀,…的] 相等的,平等的,相同的equality [见上,-ity名词后缀] 同等,平等,均等漫游,错误error /ˈer.ɚ/ 错误errant /'ɛrənt/ adj. 错误的aberrant /æ'bɛrənt/ adj. 异常的;畸变的erroneous /ɪ'ronɪəs/ adj. 错误的;不正确的errant [err漫游,-ant形容词后缀,…的] 周游的,飘泊的error [err漫游,走→走离正道→走错,-or抽象名词后缀] 错误,谬误Eugenics /jʊ'dʒɛnɪks/ n. 优生学eulogy /'jʊlədʒi/ n. 颂扬eulogize/'jʊlə'dʒaɪz/ v. 称赞euphony /'jʊfəni/ n. 悦耳euphonious /ju'fonɪəs/ adj. 悦耳的时代,年龄Coeval /ko'ivl/ adj. 同时代的Medieval /,midɪ'ivəl/ adj. 中世纪的Longevity /lɔn'dʒɛvəti/ n. 长寿Primeval /praɪˈmiː.vəl/ adj. 原始的ev=age年龄,寿命,时代,时期longevity [long长,ev年龄,寿命,ity名词后缀] 长寿,长命coeval [co-共同,ev时代,-al形容词后缀] 同时代的,同年代的,同时期的;[-al名词后缀] 同时代的人(或物)(额)外Extradite /ˈə.daɪt/ v. 引渡Extrovert /ˈə.vɝːt/ n. 性格外向的人extraneous /ɪkˈstreɪ.ni.əs/ adj. 无直接关系的extravagant /ɪk'strævəgənt/ adj. 过度的出,出去,向外,向上exhumeE拓展e-/ef- 表示出,出来,efficiency效率em-/en-, 表示进入... 之中,包围,使..... 进入状态ex- 表示出,出去,前面的,前任的exo- 表示外部的,外面ed 吃ed=eat吃edible [ed吃,-ible形容词后缀,可…的] 可以吃的,食用的edacious [ed吃,-acious形容词后缀,表示有…性质的,好…的] 贪吃的,狼吞虎咽的ego我ego 自我,自负egoism [ego自我,-ism主义] 自我主义,利已主义enn/ann 年F-G-HFac-/fact/fect/fict/fec/fic/fig 做通假关系:错的东西,表示一类malefaction /ˌmælə'fækʃən/ n. 犯罪行为benefaction /ˈbɛnəˌfækʃən/ n.善行facile /ˈfæs.əl/ adj. 轻率的,未经深思熟虑的facilitate /fəˈsɪl.ə.teɪt/ v. 促进,促使fact=do,make做,作(fact也作fac)factory [fact作,制作,-ory名词后缀,表示场所,地点;“制作的场所”] 工厂,制造厂manufacture [manu手,fact作,制作;“用手制作”,古时生产用手操作] 制造,加工effect68. Fall- 犯错误,欺骗fallacy /ˈfæl.ə.si/ n. 谬见,谬论fallacious /fəˈleɪ.ʃəs/ adj. 错误的,谬误的infallible /ɪnˈfæl.ə.bəl/ adj. 不可能错误的fallible /ˈfæl.ə.bəl/ adj. 会犯错误的,容易出错的69. Fid- 相信confident /ˈkɑːə.dənt/ adj. 自信的,有信心的confidential /ˌkɑːəˈden.ʃəl/ adj. 秘密的,机密的perfidy /ˈpɝː.fə.di/ n. 背信弃义(行为)federal /ˈfed.ɚ.əl/ adj. 联邦政府的confidence [con-加强意义,fid信任,-ence名词后缀] 信任,信心,自信self-confidence [self自己,confidence信任,信心] 自信/fict,塑造,虚构,塑形(做)Figure /ˈfɪɡ.jɚ/ n. 数字;外形,轮廓figment /ˈfɪɡ.mənt/ n. 凭空想象的事物,臆造的东西transfigure /trænsˈfɪɡ.jɚ/ v. 使变样,使改观configuration /kənˌfɪɡ.jəˈreɪ.ʃən/ n. 布局,构造fiction [fict虚构,杜撰,-ion名词后缀] 虚构,杜撰,捏造;[虚构的事] 小说figure [fig塑造,制作,-ure名词后缀,’制作出来”的样子,’塑造成”的形状] 外形,轮廓,塑像,形象71. Fin- 范围finish /ˈfɪn.ɪʃ/ v.完成,(使)完结finite /ˈfaɪ.naɪt/ adj. 有限的infinite /ˈɪə.nət/ adj. 无限的,无边的confine /kənˈfaɪn/ v. 把...局限在,限制72. Flect/flex-折deflect /dɪˈflekt/ v. (使)转向inflect /ɪnˈflekt/ v. 使(词)发生屈折变化;使...略作改变reflect /rɪˈflekt/ v. 反射,反映flexible /ˈə.bəl/ adj. 可变动的,灵活的73. Flu-/flow 流动Fluent /ˈfluː.ənt/ adj. 流利的affluence /ˈæfluəns/ n. 富裕,富足effluent /ˈ.ənt/ n. 废水,污水confluence /ˈkɑːː.əns/ n. 汇合处,汇流点flu=flow流fluent [flu流,-ent形容词后缀,…的] 流动的,流畅的,(语言)流利的fluency [flu流,-ency名词后缀] 流利,流畅influence [in-入,flu流,-ence名词后缀;’流入”→波及→对周围事物产生影响] 影响,感动,势力;[转为动词] 感化,影响,对…有作用,左右74. Form-形状,形式formal /ˈfɔːəl/ adj. 公开的,正式的conform /kənˈfɔːrm/ v. 顺从,遵从deform /dɪˈfɔːrm/ v. 使变形,使扭曲transform /trænsˈfɔːrm/ v. 使彻底改观,使大变样75. Fort 力量fortify /ˈfɔː̬ə.faɪ/ v. 加强,增强fortitude /ˈfɔː̬ə.tuːd/ n. 勇气,坚韧comfort /ˈkʌɚt/ n. 舒适,舒服effort /ˈef.ɚt/ n. 七里,精力76. Fract-/break/frag 打碎,打破fraction /ˈfræk.ʃən/ n. 分数fract ious /ˈfræk.ʃəs/ adj. 易怒的,暴躁的fracture /ˈfræʃɚ/ v. (使)破裂refraction /rɪˈfræk.ʃən/ v. 折射fragment [frag破,-ment名词后缀,表示物] 碎片,破片,碎块fraction [fract破,折,-ion名词后缀] 小部分,片断,分数77. Fug- 离开refuge /ˈːdʒ/ n. 避难(所)refugee /ˌəˈdʒiː/ n. 难民,避难者fugitive /ˈfjuː.dʒə.t̬ɪv/ n. 逃亡者,逃犯centrifugal /senˈtrɪə.ɡəl/ adj. 离心的78. Funct- 活动,to performfunctionary /ˈfʌŋk.ʃə n. 工作人员,公务员malfunction /ˌmælˈfʌŋk.ʃən/ v. 运转不正常,发生故障defunct /dɪˈfʌŋkt/ adj. 不复存在的,死亡的dysfunctional /dɪsˈfʌŋk.ʃən.əl/ adj. 失调的,失常的F拓展fore- 表示前面,预先fer/phor 带,拿fer=bring,carry带拿confer [con共同,一起,fer拿;把意见“拿到一起来”] 协商,商量,交换意见differ [dif-分开,fer拿,持;“分开拿”,“分取”,“各持已见”,“各执一词”→互异] 不同,相异,意见不同prefer [pre-先,fer拿,取;对某物’先取”,’先选”,宁愿’先要”某事物]宁可,宁愿(选择),更喜欢…,偏爱…flor 花flor=flower花(flor也作flour)florist [flor花,-ist表示人] 种花者,花卉研究者flourish [flour花,-ish动词后缀;’如开花一样”] 繁荣,茂盛,兴旺,昌盛fus 倒灌fus=pour灌,流,倾泻refuse [re-回,fus流;’流回”→倒灌,倒流→退回→不接纳] 拒绝,拒受confuse [con-共同,合,fus流;’合流”,’流到一处”→混在一起]使混杂,混乱,混淆,使迷乱fabl/fabul言fable [fabl言] 寓言,传说fabulist [fabul言,-ist…人] 寓言家,撒谎者feder联盟federate [feder聪明,-ate形容词兼动词后缀] 同盟的,联邦的;(使)结成联盟(成联邦) federation [feder联盟,-ation名词后缀] 聪明,同盟,联合会,联邦政府ferv沸,热fervid [ferv热,-id形容词后缀,…的] 炽热的,热情的,热烈的fervor [ferv热,-or抽象名词后缀] 炽热,热情,热烈fil线file [fil线,’人或物排列成一条线”] 行列,纵列profile [pro-向前,fil线→线条;’用线条勾画”] 描画…的轮廓,外形,轮廓,侧面像flat吹inflate [in-入,flat吹;’吹入气体”] 使充气,使膨胀,使通货膨胀inflator [见上,-or表示人或物] 充气者,充气机,打气筒flect/flex弯曲reflect [re-回,flect弯曲;’弯回”折回,返回] 反射,反映flex 弯曲,折曲flict打击afflict [af-表示at,to等意义,flict打击] 使苦恼,折磨conflict [con-共同,flict打击,’共同打”→彼此互打] 冲突,战斗,交锋,斗争frig冷frigidity [firg寒冷,-idity名词后缀] 寒冷,冷淡refrigerator [见上,-or表示物] 冰箱,冷冻机,冷藏库fug逃,散refuge [re-回,fug逃;’逃回”到安全地方] 避难lucifugous [luci光,fug逃避,-ous…的] 避日光的fund/found底,基础fund [fund基础;’创办事业的基础”,’底子”→本钱] 基金found [found基础] 为(房屋等)打基础,建立,创立founder [见上,-er者] 奠基者,创立者foundress [见上,-ress表示女性] 女奠基者,女创立者出生,产生generate /ˈdʒen.ə.reɪt/ v. 造成,使存在generation /ˌdʒen.əˈreɪ.ʃən/ n. 年龄层,同代人generator /ˈdʒen.əɪ.t̬ɚ/ n. 产生器,发电机genesis /ˈdʒen.ə.sɪs/ n.形成,发生,起源81. Geo- 地Geology /dʒiˈɑː.lə.dʒi/ n. 地质学Geometry /dʒiˈɑː.mə.tri/ n. 几何学geophysics /ˌdʒiː.əˈfɪz.ɪks/ n. 地球物理学geocentric /ˌdʒiː.oʊˈɪk/ adj. 以地球为中心的82. Gni/gno-/kno 知道gnosis /'noʊsɪs/ n. 直觉,真知agnostic /æɡˈnɑː.stɪk/ n. 不可知论的,不可知论者ignore /ɪɡˈnɔːr/ v. 不理睬cognitive /ˈkɑːɡ.nə.t̬ɪv/ adj. 感知的83. Grad- 级别gradual /ˈɡrædʒ.u.əl/ adj. 逐步的,平缓的degrade /dɪˈɡreɪd/ v. 使失去价值,贬低upgrade /ʌpˈɡreɪd/ v. 提升,提拔,使升级centigrade /ˈ̬ə.ɡreɪd/ n.摄氏温度grad=step,go,grade步,走,级gradual [grad步,-ual形容词后缀,…的] 逐步的,逐渐的graduate [grad步,级,-u-,-ate动词后缀;’在学业上走完某一步”,’在学业上完成某一级”] 毕业;[转为] 毕业生84. Graph- 写biograph y /baɪˈɑː.ɡrə.fi/ n. 传记telegraph /ˈtel.ə.ɡræf/ n. 电报,电报机monograph /ˈmɑː.nə.ɡræf/ n. 专题文章,专论autograph /ˈɑː.t̬ə.ɡræf/ n. 亲笔签名graph=write,writing,an instrument for making records 写,画,文字,图形,记录器photograph [photo光,影,graph写→记录;’把实物的影像录下来”]照相,拍照,摄影,照片phototgraphy [见上,-y名词后缀] 摄影术Grat- 感激,开心great感激gratitude /ˈɡræt̬.ə.tuːd/ n.感激之情,感谢gratify /ˈɡræt̬.ə.faɪ/ v使高兴,满足grateful /ˈɡreɪəl/ adj. 感激的ingrate /ˈɪŋ.ɡreɪt/ n. 忘恩负义者86. Grav- 重grave /ɡreɪv/ n. 坟墓aggravate /ˈæɡ.rə.veɪt/ v. 使更糟,加剧gravity /ˈɡræv.ə.t̬i/ n. 力量,重力,引力gravitate /ˈɡræv.ə.teɪt/ v. 被吸引,受重力作用gravid [grav重,-id…的;’负重的”,’重身子”,’heavy with child”] 怀孕的,妊娠的grave [grav重] 重大的,严重的87. gre/cret/creas- 增长creature /ˈkriː.tʃɚ/ n. 生物increase /ɪnˈkriːs/ v. 增大,增加decrease /ˈdiː.kriːs/ v. 使减少procreate /ˈproʊ.ɪt/ v. 生殖88. greg- 群体,集合aggregate /ˈæɡ.rə.ɡət/ n. 合计,总数,聚集体congregate /ˈkɑːŋ.ɡrə.ɡeɪt/ v. 聚集segregate /ˈseɡ.rə.ɡeɪt/ v. 分离gregarious /ɡrɪˈɡ.əs/ adj. 爱交际的congregate [con-共同,greg集合,-ate动词兼形容词后缀](使)集合;集合在一起的,集体的segregate [se-分开,离开,greg群,-ate动词后缀;’离群”,’离开集体”](使)分离,(使)分开,使隔离G拓展gram 写gram=write,something written of drawn 写,画,文字,图形grammar [gram写,文字,m重复字母,-ar名词后缀;关于’文字的法则] 语法,文法program [pro-在前面,gram写-书,表,单;’写在前面的说明文字”]节目单,戏单,说明书,大纲,方案gress 行走gress=go,walk行走progress [pro-向前,gress行走] 前进,进步congress [con-共同,一起,gress走,来到;’大家走到一起来”→共聚一堂→开会→会议] (代表)大会,国会,议会gam婚姻monogamy [mono-单一,gam婚姻,-y名词后缀;’单婚”,一夫一妻] 一夫一妻制bigamy [bi-双,重,gam婚姻,-y名词后缀] 重婚(罪)gran谷物,谷粒granary [garn谷物, -ary表示场所,地点] 谷仓,粮仓,产粮区grange [gran谷物;’生产谷物的地方”] 农场,农庄,田庄gyn/gynec(o)妇女gynecology [gyneco妇女,-logy…学] 妇科学,妇科philogyny [philo爱好,gyn妇女,-y名词后缀] 对女人的爱好,爱女人89. hemi/semi- 半hemisphere /ˈhem.ə.sfɪr/ n. 半球hemicycle /'heməˌsaɪkəl/ n. 半圆形semiautomatic /ˌ.ɑː.t̬əˈmæt̬.ɪk/ adj. 半自动的semiconductor /ˌənˈdʌɚ/ n. 半导体90. Her- 粘inherent /ɪnˈhɪr.ənt/ adj. 内在的,固有的incoherent /ˌɪʊˈhɪr.ənt/ adj. 语无伦次的cohere /koʊˈhɪr/ v. 连贯,使结合为一体adherent /ədˈhɪr.ənt/ adj. 黏性的91. Hes- 粘adhesive /ədˈhiː.sɪv/ n. 粘合剂,有黏性的cohesion /koʊˈhiː.ʒən/ n.凝聚力hesitate /ˈhez.ə.teɪt/ v. 踌躇hesitation /ˌhez.əˈteɪ.ʃən/ n. 犹豫hes,her粘着hesitate [hes粘着,-it-,-ate动词后缀;’粘着”在固定地方→踌躇不前,裹足不前]踌躇,犹豫adhere [ad-表示at ,to,her粘] 粘附,胶着,依附92. Hol/holo- 全部holistic /hoʊlˈɪɪk/ adj. 全面的hologram /ˈhɑː.lə.ɡræm/ n. 全息影像holocaust /ˈhɑː.lə.kɑːst/n. 大屠杀,浩劫93. hypo- 在…下面Hypothesis /haɪˈpɑː.θə.sɪs/ n. 假设hypothetical /ˌhaɪ.pəˈθe t̬.ɪ.kəl/ adj. 假设的Hypocrite /ˈhɪp.ə.krɪt/ n. 伪君子Hypodermic /ˌhaɪ.poʊˈdɝː.mɪk/ adj. 皮下注射的94. hydr- 水hydrous /'haɪdrəs/ adj. 含水的dehydrate /ˌdiː.haɪˈdreɪt/ v. 脱水hydrant /ˈhaɪ.drənt/ n. 消防栓hydroelectric /ˌhaɪ.droʊ.ɪˈɪk/ adj. 水力发电的95. hyper- 超过hyperactive /ˌhaɪ.pɚˈæɪv/ adj. 过度活跃的hypersensitive /ˌhaɪ.pɚˈə.t̬ɪv/ adj. 过于敏感的hypercritical /ˌhaɪ.pɚˈkrɪt̬.ɪ.kəl/ adj. 过分挑剔的hypertension /ˌhaɪ.pɚˈten.ʃən/ n. 高血压H拓展hecto- 表示百,许多hepta- 表示七hetero- 表示异类,异种hexa- 表示六homo- 表示同类的habit 居住habit=dwell居住habitant [habit居住,-ant表示人] 居住者cohabit [co-共同,habit居住] (男女)同居,姘居hibit 拿hibit=hold拿,持exhibit [ex-外,出,hibit拿,持;’拿出去”→摆出去给人看]展出,展览,陈列,展示,显示inhibit [in-表示in,hibit持,握;’to hold in”,’to maintain in”] 阻止,禁止,抑制hospit 客人hospit=guest客人hospital [hospit客人,-al名词后缀;原义为接待’客人”的地方→接待’病客”的地方] 医院hospitalize [见上,-ize动词后缀] 把…送入医院治疗hal呼吸inhale [in-入,hal呼吸;’to breathe in”] 吸入,吸气exhale [ex-出,hal呼吸;’to breathe out”] 呼出,呼气helic(o)螺旋helicopter [helico螺旋,旋转,pter翼;’装有旋转的翼”,利用”旋翼”飞行] 直升飞机heliport [heli=helicopter] 直升飞机场harm 伤害harmony 和谐的i-J-K-L96. iatr- 治疗pediatrics /ˌpidiˈætrɪks/ n. 儿科学podiatrist /pəˈdaɪ.ə.trɪst/ n. 足科医生97. Icon- 想象icon /ˈaɪ.kɑːn/ n. 电脑符号,图示iconic /aɪˈkɑː.nɪk/ adj. 非常出名的,受欢迎的iconography /ˌaɪ.kəˈnɑː.ɡrə.fi/ n. 图示,象徽98. Idio- 个人idiom /ˈɪ.əm/ n. 习语,成语idiomatic /ˌɪ.əˈmæt̬.ɪk/ adj. 成语的,习语的ideograph /'ɪdɪrɡrɑ:f/ n. 象形文字idiot /ˈɪ.ət/ n. 白痴,笨蛋pilot /ˈpaɪ.lət/ n. 航空器,飞行员patriot /ˈpeɪ.tri.ɑːt/ n. 爱国者idio=peculiar,own,private,proper特殊的,个人的,专有的idiot [idio特殊的;’特殊的人”→异予正常人的人] 傻子,痴人,白痴idiograph [idio个人的,专有的,graph写,文字,图形] 个人的签名,商标99. Inter- 在..之间interstice /ɪnˈtɝː.stɪs/ n. 裂缝,间隙intercede /ˌɪɚˈsiːd/ v. 求情interview /ˈɪɚ.vjuː/ n. 面试,面谈interpersonal /ˌɪɚˈpɝː.sən.əl/ adj. 人际的interrupt 打断,插嘴100. idea/ideo=idea,表示“思想,观点”ideal /aɪˈdiː.əl/ adj. 完美的,理想的idealism /aɪˈdiː.ə.lɪ.zəm/ n. 理想主义idealize /aɪˈdiː.ə.laɪz/ v. 使...理想化ideology /ˌaɪ.diˈɑː.lə.dʒi/ n. 思想意识;观念学101. itis -炎症otitis /oʊˈtaɪ.t̬ɪs/ n. 耳炎gastritis /ɡæsˈtraɪ.t̬əs/ n. 胃炎il-/ir- 辅音重复表示不,无,使.....成为,进入im-/in- 表示不,无,非,向内,进入m-n通假关系intra- 表示在内,内部infra 下面intro- 表示向内,入内iso- 表示等, 同insul 岛insul=island岛insulate [insul岛→孤立→与外界隔绝,-ate动词后缀,使…;’使成岛状”→使孤立,使与…隔绝] 隔离,使孤立,使绝缘insulin [insul岛,-in名词后缀,表示’素”] 胰岛素it 走it=go行走exit [ex-出,外,it行走;’走出”,’向外走”] 出口,太平门,退出circuit [cire圆,环,-u-,-it行] 环行,周线,电路,回路ign火ignite [ign火,-ite动词后缀] 点燃,点火于,使燃烧,着火ignition [ign火,-ion名词后缀] 点火,着火integr整,全integral [integr整,全,-al…的] 完整的,整体的integrality [见上,-ity名词后缀] 完整性,完全运动系统词根词缀总结第3篇brachi 臂,分支,分流steth 胸oste 骨cran 颅骨stern 胸骨vertebr/spondyl 椎骨,脊椎radi 桡骨,辐射,根(如牙根)carp 腕骨chondr 软骨humer 肱骨ischi 坐骨femur 股骨ili 髂骨tibia 胫骨ten/tenein/tenon/tenont/tend/tendin 筋,腱fasci 筋膜fibr 纤维sarc 肉(词源flesh)muscul/my 肌肉(词源muscle)arthr 关节myel 髓orth 直,正(ankylosis关节强直)orthopedist整形外科医生;orthopedics骨科,矫正术orthopnea端坐呼吸;platypnea仰卧呼吸lei 平滑的(leiomyoma平滑肌瘤)-asthenia 无力-sthenia 有力anesthesia为麻醉,其中esthes为词根“感觉,知觉”-blast 胚细胞,成……细胞(chondroblast成软骨细胞)-clast 破……细胞(chondroclast破软骨细胞)-cele 疝,突出-ceps 头(biceps二头肌;triceps三头肌)-cyte 细胞-trophy 发育,营养-phyte 赘,多余(arthrophyte关节赘疣)-dystrophy 营养不良-cyst 囊肿-schisis 裂(ganthoschisis颌裂)-listhesis 滑动-malacia 软化-oid ……类的(steroid类固醇)-physis 生长symphysis=synphysis合生,连体,尤指骨愈合-porosis 洞孔,通道(osteoporosis骨质疏松)restr- 前面的anter- 后面的。
大肠杆菌发酵经验总结
大肠杆菌发酵经验总结首先,补料速率与比生长速率直接影响着乙酸的生成速率和积累量(主要是补料速率与比生长速率影响发酵液中的残糖量,进而影响),所以适当的控制补料速率和比生长速率,对于控制乙酸的量有很好的效果。
其次,必须要保证充足的溶氧,并严格控制pH值,而且补酸碱的速率尽量缓和,不能太快;温度对于蛋白的表达也有很重要的影响,较低的发酵温度下所生产出的蛋白大多是有活性的,而较高的发酵温度下产生的蛋白大多一包涵体形式存在。
第三,选取合理的诱导时间非常重要,一般的诱导时间选在指数生长后期,而且诱导时的比生长速率最好能控制在0.2之内,选在此时诱导,1.将菌体的快速生长期与蛋白合成期分开,使这两个阶段互不影响,有利于蛋白的高表达;2.已经得到了大量的菌体,而且菌体的生物量基本接近稳定,不论是从动力学角度,还是能耗,物料成本方面,都比较合理。
第四,补料过程中的碳氮比也很重要。
若氮源过高,会使菌体生长过于旺盛,pH偏高,不利于代谢产物的积累,氮源不足,则菌体繁殖量少从而影响产量;碳源过多,则容易刑场较低的pH,抑制菌体生长,碳源不足,则容易引起菌体的衰老和自溶。
另外,碳氮比不当还会引起菌体按比例的吸收营养物质,从而直接影响菌体的生长和产物的合成。
根据自己的经验,一般情况下,对于一个稳定的发酵工艺下,如果总是在固定的发酵时间段出现溶菌现象,而且能排除噬菌体和染菌的可能性后,那就可能是因为碳氮比不合理造成的。
可以适当调整碳氮比。
大家讨论得较多的是关于代谢副产物乙酸对大肠杆菌发酵的影响,针对我们论坛所发的帖,我先总结以下几点,并作出相应解决措施。
一、代谢副产物-乙酸乙酸是大肠杆菌发酵过程中的代谢副产物,在多大的浓度下产生抑制作用各种说法不一,一般认为在好气性条件下,5~10g/L 的乙酸浓度就能对滞后期、最大比生长速率、菌体浓度以及最后蛋白收率等都产生可观测到的抑制作用。
当乙酸浓度大于10或20g/L 时,细胞将会停止生长,当培养液中乙酸浓度大于12g/L 后外源蛋白的表达完全被抑制。
美洲大蠊、斑蝥提取物对3株人肿瘤细胞增殖抑制作用的研究
美洲大蠊、斑蝥提取物对3株人肿瘤细胞增殖抑制作用的研究目的:研究从昆虫美洲大蠊和斑蝥中提取的3个活性部位YS-I、YS-II、YS-III 对人胃癌细胞MGC-803、人食管癌细胞Eca-109和人肝癌细胞HepG2增殖的抑制作用。
方法:将从昆虫美洲大蠊、斑蝥中提取的3个活性部位分别作用于MGC-803、Eca-109、HepG2細胞株,采用MTT法检测受试物作用24、48、72小时后细胞增殖抑制情况,计算IC50值,并研究其量效、时效关系。
结果:3个由昆虫中提取的活性部位对人源MGC-803、Eca-109、HepG2肿瘤细胞株均有一定的增殖抑制作用,并呈现较好的时间依赖和剂量依赖关系。
结论:美洲大蠊提取物YS-I及斑蝥不同极性提取物YS-II、YS-III对人胃癌、食管癌、肝癌细胞具有较好的增殖抑制作用,为今后进一步研发昆虫源低毒、高效的抗肿瘤药物奠定了一定基础。
标签:昆虫;美洲大蠊;斑蝥;增殖抑制;抗肿瘤Proliferation Inhibition of Extracts from Reriplaneta amerlcana and Mylabris on Three Human Tumor CellsYAN Shuang1,2GAO Meng ting1,2ZHENG Yuanyuan1,2GUO Nana1,2CHEN Junya2GEN Ling2XIAO Huai1,2,3,4LI Yue1,2,3,4*1Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D,Dali 671000,China;2College of Pharmacy and Chemistry,Dali University,Dali 671000,China;3Yunnan Provincial 2011 Collaborative Innovation Center for Entomoceutics,Dali 671000,China;4National-Local Joint Engineering Research Center of Entomoceutics,Dali 671000,ChinaAbstract:Objective To study the proliferation inhibition on MGC-803 cell、Eca-109 cell and HepG2 cell with three active extracts(YS-I,YS-II,YS-III)from Periplaneta americana and Mylabris Methods To incubate MGC-803、Eca-109 and HepG2 cell with three active extracts from Periplaneta americanaand Mylabrisfor 24,48 and 72 hours,cell proliferation in different concentration and time was determined by MTT assay Calculating IC50 values and study its dose,time-effect relationship Results Three active extracts frominsects have a certain proliferation inhibition on MGC-803 cell,Eca-109 cell and HepG2 cell The inhibition effect had good time-dependent and dose-dependent Conclusion Three active extracts fromPeriplaneta americanaand Mylabrishave a good proliferation inhibition on MGC-803,Eca-109 and HepG2 cell Laying a foundation for further research and development of low toxicity,efficient insect anti-tumor drugs.Keywords:Insects;Periplaneta americana;Mylabris;Proliferation Inhibition;Antitumor恶性肿瘤对人类生命健康危害极大,世界卫生组织发布的《2014年世界癌症报告》提及未来20年每年新发癌症病例将达到2200万,同期癌症死亡数将上升至1300万例[1]。
鱼用疫苗免疫途径的研究概况(下)
2.提高口服免疫效果的措施口服疫苗免疫效果并不十分理想,主要是由于抗原受到胃酸的作用和蛋白酶的水解,使抗原到达后肠部位时,其完整性和免疫部位已被破坏或抗原被消化掉,没有足够的抗原到达后肠(Quentel C等,1997)。
因此,为了使抗原在鱼的前肠不被消化,则发展了许多的包裹材料来保护抗原。
现如今,常用的有海藻酸钠、明胶、聚交酯醣酯聚合物、卤虫、生物被膜等材料。
(1)海藻酸钠。
海藻酸钠是一种天然多糖类化合物,是从褐藻中提取而来的,现已作为包裹药品和细胞的材料,具有药物制剂辅料所需的稳定性、溶解性、黏性和安全性等特性(Chan L W等,2002),Joosten等(1997)用海藻酸钠包裹溶藻弧菌免疫虹鳟和鲤鱼,其结果显示在鱼体中有抗体产生。
Tian等(2008)用海藻酸钠包裹含有能够表达淋巴囊肿病毒蛋白的质粒进行口服免疫日本牙鲆,检测免疫3~16周牙鲆的抗体效价,表明其效果明显。
Romalde等(2004)认为通过口服海藻酸钠微囊化的疫苗虽然不能作为初次免疫的方法,但对鱼有较好的保护效果。
Altun等(2010)也用海藻酸钠包裹L.garvieae bacterin疫苗口服免疫虹鳟鱼,其结果表明,在免疫30天后的RPS为53%,61天后对鱼体进行二次免疫,120天时其RPS达到61%,效果明显。
李新华等(2007)用海藻酸钠包裹嗜水气单胞菌疫苗口服免疫银鲫,结果表明微胶囊疫苗组血清抗体效价较高,且维持时间长,对口服免疫效果有明显的提升。
(2)聚交酯醣酯聚合物。
目前,聚交酯醣酯聚合物也被应用于鱼类口服疫苗的包裹技术上,它是一种疏水型的聚酯(Tian J Y等,2008),降解性好且无毒,而且容易生产,价格便宜。
Tian等(2008)利用聚交酯醣酯聚合物包裹LCDV的DNA疫苗免疫日本牙鲆,免疫90天后,在日本牙鲆体内各组织中检测到LCDV的mRNA,而且用ELISA在1~24周均可检测到抗体。
Altun等(2010)分别利用聚交酯醣酯聚合物和海藻酸钠包裹L.garvieae bac-terin免疫虹鳟,聚交酯醣酯聚合物为包裹材料的免疫效果比海藻酸钠为包裹材料的好。
2006-@@Cultivated microalgae and the carotenoid fucoxanthin from=FX=抗癌-齿状藻-金藻
Environmental Toxicology and Pharmacology22(2006)97–103Cultivated microalgae and the carotenoid fucoxanthin fromOdontella aurita as potent anti-proliferative agentsin bronchopulmonary and epithelial cell linesDimitri Moreau a,∗,Christophe Tomasoni a,Catherine Jacquot a,Raymond Kaas b,Roland Le Guedes b,Jean-Paul Cadoret b,Arnaud Muller-Feuga b,Ioanna Kontiza c,Constantinos Vagias c,Vassilios Roussis c,Christos Roussakis aa Laboratoire de Pharmacologie Marine,ISOMer,Facult´e de Pharmacie de Nantes,1rue Gaston Veil,BP92208,44322Nantes Cedex03,Franceb Laboratoire de Physiologie et Biotechnologie des Algues,IFREMER,rue de l’ˆıle d’Yeu,BP1105,44311Nantes Cedex03,Francec University of Athens,Department of Pharmacy,Division of Pharmacognosy and Chemistry of Natural Products,Panepistimiopolis Zografou,Athens15771,GreeceReceived10November2005;accepted9January2006Available online6March2006AbstractThe antiproliferative activities of several extracts from cultivated microalgae in France have been studied against bronchopulmonary and epithelial cell lines,respectively(A549,NSCLC-N6and SRA01/04).The algal extracts,of Diatomae(Odontella aurita,Chaetoseros sp.),as well as of Haptophyceae:Isochrisys aff.galbana,appeared as the most active among all the assayed species,expressing a broad spectrum of in vitro antiproliferative activity of well-differentiated pathologic cells such as NSCLC-N6by terminal differentiation.Bio-guided fractionation of the above referred extracts,led us to the isolation,of the carotenoid fucoxanthin.Fucoxanthin has been structurally determined,through modern spectral means and has been studied separately for its activities.©2006Elsevier B.V.All rights reserved.Keywords:Odontella aurita;Antiproliferative activities;Bronchopulmonary carcinoma;Secondary cataract;Apoptosis;Fucoxanthin1.IntroductionMarine microalgae comprise the largest group of living organisms in the oceans,constituting an estimated10,000 species.Algae are at the base of entire aquatic food chain.There-fore,it is not surprising that the microalgae,which compose the phytoplankton,play a vital role in the rearing of aquatic animals like molluscs;shrimps andfish.Moreover,there are numerous applications for molecules from these phototropic microorganisms in human and animal food,health and cosme-tology(Muller-Feuga,2000).In recent years,there has been a growing interest in functional foods,that is,foods able to provide additional physiological benefits for human health,other than the basic nutritional and∗Corresponding author.Tel.:+33251125672;fax:+33251125690.E-mail address:dimitri.moreau@univ-nantes.fr(D.Moreau).energetic requirements(Bidlack,1994).Often,functional foods are traditional foods enriched with an ingredient able to pro-vide or promote a specific beneficial action for human health. These are called functional ingredients.These ingredients are preferred to have a natural origin,such as plants or perhaps algae and/or microalgae.These types of marine sources are receiving increasing attention mainly for their content in,for example,polyunsaturated fatty acids and,-carotene and other pigments(antioxidants),sulphated polysaccharides and sterols (antimicrobials).One of the main interests in our laboratories is to assess the suitability obtained from extracts and pure compounds from cul-tivated microalgae,like the ones which they have been studied, as food antioxidants and preventative agents against secondary cataracte and cancer.In this work,a preliminary screening of ten marine and fresh water species from different orders(Diatomophyceae, Rhodophyceae,Haptophyceae,Cryptophyceae,Prasinophyceae1382-6689/$–see front matter©2006Elsevier B.V.All rights reserved. doi:10.1016/j.etap.2006.01.00498 D.Moreau et al./Environmental Toxicology and Pharmacology22(2006)97–103Table1Detail of the different strains studied,with the source and the optimal condition of growingOrder Species Source Medium pH T(◦C) Diatomophyceae Odontella aurita IFREMER Conway7.520 Chaetoceros ap1010/11Conway7.520Porphyridium purpureum SAG111/79Hemerick720 Rhodophyceae Rhodella violacea SAG115/79Conway724 Galdieria sulphuraria a074W Galdi245 Chlorophyceae Chlamydomonas reinhardtii a PG27MMG/TAP724 Haptophyceae Isochrysis affinis galbana IFREMER Conway720 Cryptophyceae Rhodomonas salina ccap978/24Conway722 Prasinophyceae Tetraselmis suecica ccmp904Conway720 Dinophyceae Heterocapsa triquetra IFREMER ESP7.822 G.sulphuraria source:Institut f¨u r biologie,Freie Universit¨a t,Berlin.a Fresh water microalgae.and Dinophyceae)were investigated as natural source of antipro-liferative agents in vitro against asynchronous cells of human non-small-cell bronchopulmonary carcinoma line(NSCLC-N6) (Roussakis et al.,1991),human lung epithelial cell line(A549)and against a proliferative human lens epithelial cell line(SRA 01/04).Bio-guided fractionation of the extracts,which appeared as the most active,led us to the isolation of the carotenoid fucox-anthin,which has been also thoroughly assayed.In all cases,theTable2Composition of the different media used for algal cultureProducts MediumHemerick Conway Galdi MMG/TAP ESP NaNO3(g L−1) 1.70.10.07 (NH4)2SO4(g L−1) 1.5NH4Cl(g L−1)0.4K2HPO4,3H2O(g L−1)0.1750.106KH2PO4(g L−1)0.1750.30.053NaH2PO4,H2O(g L−1)0.02Na2C3H7O6P,5H2O(g L−1)0.01 Na2SiO3,5H2O(g L−1)0.1FeEDTA0.050.014Na2EDTA,2H2O(g L−1)0.0490.0450.008 CaCl2,2H2O(g L−1) 1.470.020.05KCl(g L−1)0.75MgSO4,7H2O(g L−1)12.30.30.1MgSO4,H2O(g L−1)0.00082 NaCl(g L−1)29.0Tris(g L−1)0.1Co(NO3)2,6H2O(g L−1)0.08CoCl2,6H2O(g L−1)20.080 2.927CoSO4,7H2O(g L−1)0.09124 CuSO4,5H2O(g L−1)0.0820.0160 2.855Fe(NH4)2(SO4)2,6H2O(g L−1)3510 FeCl3,6H2O(g L−1) 1.3245 FeSO4,7H2O(g L−1)9.073H3BO3 2.033.6572020.735700 MnCL2,4H2O(g L−1) 1.80.3636409.2Mo7O24(NH4)6,4H2O(g L−1)209.0260 2.0NaVO3,4H2O(g L−1)80O5SV,5H2O(g L−1)0.043ZnCl2(g L−1)21ZnSO4,7H2O(g L−1)0.2130.444011000 Vitamin B12(g L−1)102 Thiamin(g L−1)200100 Biotin(g L−1)1QSP L(g L−1)FW MW FW FW MW Mineral nutrient and their concentration(1×).D.Moreau et al./Environmental Toxicology and Pharmacology22(2006)97–10399 Table3IC50for all assayed microalgal extracts,with different solvents,against three cell linesSpecies Cell linesSRA A549NSCLC-N6EtOH CH2Cl2H2O EtOH CH2Cl2H2O EtOH CH2Cl2H2OO.aurita18.4±1.418.2±0.49.1±1.3––20.6±0.555.8±3.736.9±1.542.6±5.8 Chaetoceros sp.15.5±0.513.5±0.97.8±0.3–41.5±3.861.1±8.6–13.5±2.4–P.purpureum––0.5±0.1––13.9±0.4–– 6.3±0.5 R.violacea–26.7±2.550.8±2.6––––––G.sulphuraria41.3±3.810±0.6<0.366±0.05–37.3±2.59.1±1.3–18.7±2.5 4.8±0.5 C.reinhardtii––11.1±0.3––16±2.2–36.6±0.624.6±2 I.affinis galbana20.7±3.425.4±1.726.2±1.424.6±1.340.7±2.6–21.6±4.314.5±1.817.3±2.8 R.salina28.1±1.58.2±1.5–––––––T.suecica–12.3±2.5–––––45.3±10.117.6±5 H.triquetra19.7±1.436.8±1.58.2±1.6–––21.4±2.4–13.8±0.3 The results are expressed ing/ml.studied organisms were isolated from natural population and cultured in controlled manner in laboratory(Muller-Feuga et al.,2003).In the literature,there are several reports on the fatty acid, lipid,amino-acids and sugar composition of almost all microal-gae used in mariculture(V olkman et al.,1989;Servel et al.,1989; Brown,1991),because mostly of the importance of these data, for determining the nutritional value of the microalgae as food for animals in mariculture.Especially for the diatom Odontella aurita,the isolation and structure elucidation of a new sterol sul-fate has been published(Toume and Ishibashi,2002).No studies have been reported,to our knowledge,on any other chemical constituents of the assayed microalgae.2.Materials and methods2.1.Microalgal materials,culture conditions and chemicalsStudied species were isolated from their natural environment and were cul-tured in our laboratory.All parameters of culture(different sources of strains, culture media,pH,growing temperature conditions)are presented in details in Table1.Details on the composition of several media used are presented in Table2.Unialgal cultures were carried out in batch conditions in10l glass bot-tles,under constant light and aeration(air/CO2mixture,99:1).Every4days the medium was supplemented with1×nutrient(Table2),until the cell concentra-tion achieved the stationary phase.Water in all cases was sterile and distilled and solvents were analytical grade Cyclohexane(Lab-scan),EtOAc(Lab-scan),MeOH...Acetone,DMSO,etc.2.2.Preparation of algal extractsAll algae were recovered from culture,in the stationary phase,by centrifuga-tion at low speed and low temperature(4◦C).The algal residue was freeze dried before extraction and then it was then re-suspended in ethanol100%(400ml/g of dried weight),dichloromethane(400ml/g of dried weight)and water,respec-tively,so that three extracts of different polarities to be prepared.All extracts werefiltered,and evaporated under vacuum at low temperature(<45◦C).All organic extracts were dissolved with dimethyl sulfoxide(DMSO)and diluted in water at1mg/ml,before testing on cancer cell line.Thefinal concentration of DMSO used to dissolve extracts did not exceed0.2%and had no effect on the proliferation of the cells(results not shown).Aqueous extracts were directly diluted in water at1mg/ml.2.3.Strains and media,cell lines ad cultureThe NSCLC-N6-L16cell line(Roussakis et al.,1991),derived from a human non-small-cell bronchopulmonary carcinoma(moderately differentiated,rarely keratinizing,classified as T2N0M0),and A549obtained from ATCC collection reference CCL6185(Giard et al.,1973),were used for all experiments.Both cell lines were cultured in RPMI1640medium with5%fetal calf serum,to which were added100IU penicillin ml−1,100g streptomycin ml−1and2mM glutamine,at37◦C in an air/carbon dioxide(95:5v/v)atmosphere.In these conditions,cell doubling time was48h.Cells used in all experiments never exceeded35passages.Human Lens Epithelial cell line,SRA01/04,which was established by transfection with large T-antigen of SV40(Ibaraki et al.,1998)was cultured in antibiotic-free Dulbecco’s modified Eagle’s medium(DMEM)(Biochrom KG) supplemented with4%foetal calf serum and incubated in the same conditions described for L16and A549.2.4.Cytotoxicity determinations:continuous drug exposureExperiments were performed in96wells microtiter plates(105cells ml−1 for NSCLC-N6,2×104cells ml−1for A549and3×104cells ml−1for SRA). Cell growth was estimated by a colorimetric assay based on the conservation of tetrazolium dye(MTT)to a blue formazan product by live mitochondria (Mosmann,1983).Eight repeats were performed for each concentration.Control growth was estimated from eight determinations.Optical density at570nm Fig.1.Chemical structure of fucoxanthin.100 D.Moreau et al./Environmental Toxicology and Pharmacology22(2006)97–103corresponding to solubilized formazan was read for each well on a Titertek Multiskan MKII.2.5.Cytotoxicity determinations:discontinuous drug exposureCells were incubated for72h in96wells microtiter at the concen-tration of5×104cells ml−1for NSCLC-N6,104cells ml−1for A549and 1.5×104cells ml−1for SRA in the culture conditions described above,and in the presence or absence of the drug.After72h medium was removed,cells were washed with phosphate-buffered saline to eliminate drug traces,and then100l fresh medium containing no drug were placed in each wells.Cell growth was evaluated by the colorimetric assay of Mosmann using MTT(Mosmann,1983).2.6.Extractions and solvent fractionationDue to the results of cytotoxic assays,the dichloromethane extract of O. aurita was primary selected for the bio-guided fractionation and the isolation and determination of the active compounds.Then total dichloromethane extract wasfirst subjected to silica gel column chromatography(CC),using mixtures of CH2Cl2/acetone/EtOH(from CH2Cl2100%to EtOH100%),to affordfive frs.:fr.1has been eluted with CH2Cl2,fr.2with100%CH2Cl2,fr.3with CH2Cl2/acetone(70:30),fr.4with CH2Cl2/acetone(50:50),andfinally fr.5with 100%EtOH.After testing on NSCLC-N6cell lines,the only active fraction(fr.3) was further purified after has been subjected to vacuum column chromatography on silica gel(VLC,60H,Merck).Fifteen fractions were obtained(named frs.3.1–3.15),using100ml of mixtures of cyclohexane/EtOAc/MeOH of increasing polarity.After a new test of the purified extract,the identification of active compound was done through modern spectral means.The[M]+ion of compound3.10atm.m/z658,in combination with the 13C NMR data required a C42H58O6molecular formula.Characteristic were the overlapping peaks atδ6.09–6.69ppm consisted with conjugated double bonds intergrading for nine protons.Obvious were four singlets at1.92,1.97, 1.79,1.97resulting from four vinylic methyls,as well as a multiplet peak at5.36due to an oxidized methine.Moreover characteristic was at the13C NMR spectrum the presence of an allene moiety[δc117.5(C-6 ),202.4(C-7 ), 103.5(C-8 ).These evidences lead to the assumption that compound3.10was (3S,5R,6S,3 S,5 R,6 R)-fucoxanthine,also according to international literature (Haugan et al.,1992).2.7.Detection of apoptotic cells in fucoxanthinThe detections of apoptotic cells were performed for all three cell lines under the same conditions.Cells were incubated in the presence of15g/ml fucoxan-thin for72h;for the studied of DNA fragmentation,the DNA was extract with a classical phenol/chloroform protocol.Then an electrophoresis was performed on agarose gel for all the DNA extracts.For the observation of apoptotic cells, they were stained with10g/ml of acridin orange for15min in the dark.The results were observed using afluorescence microscope,Olympus AX70®,with exciterfilter BP450-480.3.Results and discussion3.1.Inhibitory effect of algal extracts on cell linesFor each one of the tested extracts,the concentration required to reduce cell growth by50%(IC50)was determined and results are shown in Table3for all cell lines.Almost a73%of the assayed extracts showed moderate to strong activity against SRA cell line,while only53%and30%exhibited activity against NSCLC-N6and A549cell lines,respectively.3.2.Chemical composition of active compound fromO.auritaThe concentration of frs.3and3.10required to reduce L16 cell growth by50%was determined as previously described,and their IC50were found8.5and7g ml−1,respectively,after72h of treatment.Through the NMR spectra as well through inter-national literature it has been identified that fr.3.10was pure fucoxanthin Fig.1.The thin layer chromatography of Chaeto-ceros sp.and I.aff.galbana dichloromethane extracts show a wide quantity of fucoxanthin as for O.aurita,certainly respon-sible of the activities observed.3.3.Growth inhibition by continuous and discontinuousdrug exposureFig.2illustrated the growth kinetics of NSCLC-N6cells in the presence(from5to20g ml−1)and absence(control)of the fucoxanthin.The inhibitory effect of fucoxanthin wasdose-Fig.2.Effect of the carotenoid fucoxanthin on the cell growth of NSCLC-N6 (a);A549(b)and SRA(c)cell-lines:growth kinetics versus time after continuous exposure to drug at different concentrations.The proliferation is reduced for the three cell line in a dose dependant manner and we can observe a plateau after 24h of treatment.D.Moreau et al./Environmental Toxicology and Pharmacology22(2006)97–103101Fig.3.Effect of fucoxanthin on the cell growth of the NSCLC-N6(a),A549 (b),SRA(c)cell lines:growth kinetics versus time after discontinuous exposure to drug at different concentrations.The cell growth is apparently blocked after 72h of treatment for the three cell lines at different concentration. dependent and only observed with a continuous drug exposure. The profile obtained was typical of cytostatic activity.Fig.3 depicted the growth pattern of NSCLC-N6cell line in a drug free medium with populations pre-treated for72h in the pres-ence(10–25g ml−1)and absence(control)of fucoxanthin. This results show that the effect of fucoxanthin is irreversible and confirm its cytostatic activity against NSCLC-N6cell-line since10g/ml.3.4.Induction of apoptosisFig.4has been showed that the treatment by fucoxanthin induces a DNA fragmentation typical of apoptotic cells.It can be seen a typical fragment around185bp(Au et al.,1997). The electrophoresis showed also,the same DNA ladder for the bronchopulmonary cell lines treated by fucoxanthin.The Fig.4.Agarose gel electrophoresis of the DNA extract from witness and treated cells with15g/ml ne(1):DNA marker(SmartLadder®,euro-gentec),lanes(2,3)NSCLC-N6,lanes(4,5)A549.exposure of the cells to fucoxanthin for72h,clearly induced morphological change such as rounding up,reduction of cell volume,chromatin condensation,nuclei fragmentation and for-mation of apoptotic bodies for the two bronchopulmonary cells lines(Figs.4and5).For SRA no apoptosis induction has been observed.Indeed,the greatest interests of microalgae,is that they can be produced in controlled condition with a low cost,and that they are adapted to a wide variety of environments favour to an exceptional biochemical production.In this study,a screening of new antiproliferative compounds from10different species of microalgae,has been taken place.So,a preliminary study of their crude extracts wasfirst necessary to evaluate the presence of new potent cytotoxic and/or cytostatic compounds.Then,the results have been demonstrated,the real extraordinary potential of the microalgae for the discovery of active extracts.Through this screening,it has been already permitted to identify more than10 extracts active on three cell lines and two different pathologies.After the identification,through the bioguided fractionation, of the carotenoid fucoxanthin as the responsible agent of the activity observed by the dichloromethane extracts of the diatoms microalgae,it has been also investigated the cytostatic activ-ity of this molecule.The expressed antiproliferative effect of this compound,has been studied by characterizing the kinetics of cell growth induced by continuous and acontinuous treat-ment and observing the induced apoptosis.Through all these parameters observed,can be suggested that fucoxanthin could trigger the terminal differentiation of cancerous cells in vitro. It has been already reported that fucoxanthin induces apoptosis in human leukemia,prostate and colon cancer cells(Kotake-Nara et al.,2001;Hosokawa et al.,1999,2004).Furthermore, it has been previously also demonstrated,an inhibitory effect of fucoxanthin on N-myc expression and on cell cycle progres-sion for human neuroblastoma cell line(Okuzumi et al.,1990). But it is thefirst time that it has been demonstrated an arrest in102 D.Moreau et al./Environmental Toxicology and Pharmacology 22(2006)97–103Fig.5.Observation of cells stained with acridin orange.Morphological comparison by fluorescence microscopy of treated cells by fucoxanthin and control cells (a,b)NSCLC-N6;(c,d)A549.G0/G1phase of the GOTO cells by fucoxanthin as well as that induces apoptosis in lung cancer and in human lens epithelial cells.The structures of carotenoids are of great interest,in the reduction of growth as well as in apoptosis induction,against cancer cells.Many studies have been also reported the antiox-idant activity of fucoxanthin (Nomura et al.,1997;Murakami et al.,2000).In contrast,the pro-oxidant action of carotenoids is shown to induce apoptosis through the production of reac-tive oxygen species (Palozza et al.,2003).This suggests that carotenoids act either as an antioxidant or as a pro-oxidant,in dependence on their environment.In conclusion,the studied microalgae appeared to be effi-cient and safe antiproliferative agents.Interestingly,the species O.aurita ,Chaetoceros sp.and I.aff.galbana are proved as rich sources of the carotenoid fucoxanthin.This molecule exhibited cytostatic activity and this effect could have important implica-tions for the application of mixtures of this kind of microalgae in food manufacturing and the formulation of ocular implant products used in cataract treatment.ReferencesAu,J.L.-S.,Panchal,N.,Li,D.,Gan,Y .,1997.Apoptosis:a new pharmaco-dynamic endpoint.Pharmaceut.Res.14,1659–1671.Bidlack,W.R.,1994.Functional foods:designer foods,pharmafoods,nutraceuticals.In:Goldberg,I.(Ed.),Trends in Food Science and Tech-nology,vol.6.Chapman and Hall,pp.66–67.Brown,M.R.,1991.The amino-acid and sugar composition of 16species ofmicroalgae used in mariculture.J.Exp.Mar.Biol.Ecol.145,79–99.Giard,D.J.,Aaronson,S.A.,Todaro,G.J.,Arnstein,P.,Kersey,J.H.,et al.,1973.In vitro cultivation of human tumors:establishment of cell lines derived from a series of solid tumors.J.Natl.Cancer Inst.51,1417–1423.Haugan,A.,Englert,G.,Glinz,E.,Liaaen-Jensen,S.,1992.Acta Chem.Scand.46,389–395.Hosokawa,M.,Wanezaki,S.,Miyauchi,K.,Kurihara,H.,Kohno,H.,et al.,1999.Apoptosis-inducing effect of fucoxanthin on human leukemia cell HL-60.Food Sci.Technol.Res.5,243–246.Hosokawa,M.,Kudo,M.,Maeda,H.,Kohno,H.,Tanaka,T.,Miyashita,K.,2004.Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPAR[gamma]ligand,troglitazone,on colon cancer cells.Biochim.et Biophys.Acta (BBA)-Gen.Sub.1675,113–119.Ibaraki,N.,Chen,S.C.,Lin,L.,Okamoto,H.,Pipas,J.M.,Reddy,V .,1998.Human lens epithelial cell line.Exp.Eye Res.67,577–585.Kotake-Nara,E.,Kushiro,M.,Zhang,H.,Sugawara,T.,Miyashita,K.,Nagao,A.,2001.Carotenoids affect proliferation of human prostate cancer cells.J.Nutr.131,3303–3306.Mosmann,T.,1983.Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assay.J.Immunol.Methods 65,55–63.Muller-Feuga,A.,2000.The role of microalgae in aquaculture:situation and trends.J.Appl.Phycol.12,527–534.Muller-Feuga,A.,Le Guedes,R.,Pruvost,J.,2003.Benefits and limitations of modeling for optimization of Porphyridium cruentum cultures in an annular photobioreactor.J.Biotechnol.103,153–163.Murakami,A.,Nakashima,M.,Koshiba,T.,Maoka,T.,Nishino,H.,et al.,2000.Modifying effects of carotenoids on superoxide and nitric oxide generation from stimulated leukocytes.Cancer Lett.149,115–123.Nomura,T.,Kikuchi,M.,Kubodera,A.,Kawakami,Y .,1997.Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH).Biochem.Mol.Biol.Int.42,361–370.Okuzumi,J.,Nishino,H.,Murakoshi,M.,Iwashima,A.,Tanaka,Y .,et al.,1990.Inhibitory effects of fucoxanthin,a natural carotenoid,on N-myc expression and cell cycle progression in human malignant tumor cells.Cancer Lett.55,75–81.D.Moreau et al./Environmental Toxicology and Pharmacology22(2006)97–103103Palozza,P.,Serini,S.,Torsello,A.,Di Nicuolo,F.,Piccioni,E.,et al.,2003.Carotene regulates NF-B DNA-binding activity by a redox mechanism in human leukemia and colon adenocarcinoma cells.J.Nutr.133,381–388.Roussakis,C.,Gratas,C.,Audouin,A.F.,Le Boterff,J.,Dabouis,C.,et al.,1991.Study of in vitro drug sensitivity on a newly established cell line from a primary bronchial epidermoid carcinoma of human origin (NSCLCN6).Anticancer Res.11,2239–2244.Servel,M.-O.,Claire,C.,Derrien,A.,Coiffard,L.,De Roeck-Holtzhauer,Y., 1989.Fatty acid composition of some marine microalgae.Phytochemistry 36,691–693.Toume,K.,Ishibashi,M.,2002.5[alpha],8[alpha]-Epidioxysterol sulfate froma diatom Odontella aurita.Phytochemistry61,359–360.V olkman,J.K.,Jeffrey,S.W.,Nichols,P.D.,Rogers,G.I.,Garland,C.D.,1989.Fatty acid and lipid composition of10species of microalgae used in mariculture.J.Exp.Mar.Biol.Ecol.128,219–240.。
中华绒螯蟹(eriocheirsinensis)c型凝集素的抗菌功能研究
论文摘要作为模式识别受体,C型凝集素家族(CTLs)在识别和清除病原物的过程中扮演重要角色。
在本研究中,在中华绒螯蟹中发现一种新的CTL。
根据从肝胰腺cDNA文库里分离得到的ESTs克隆得到该基因的全长。
该基因全长为685bp 含开放阅读框(ORF)468bp,可编码155个氨基酸。
氮端含有信号肽和糖类识别结构功能域(CRD)。
通过实时定量PCR技术,检测该基因mRNA大量存在于肝胰腺中,在其他组织中很少甚至没有。
经过脂多糖(LPS)的免疫刺激,该基因mRNA水平明显上调。
该重组蛋白(rEsLecD)可以结合多种微生物,包括革兰氏阴性菌、革兰氏阳性菌和真菌。
同时,钙离子的存在可以增强该重组蛋白对细菌的结合能力,但钙离子在结合实验中不是必须的。
该重组蛋白与细菌的结合继而诱导病原微生物的凝集。
另外我们检测到这种重组蛋白能够抑制细菌的生长,并且有一定的杀菌作用。
更有趣的是,该重组蛋白可以引发血细胞体外包裹。
总之本研究结果预示着,该凝集素蛋白作为抗菌模式识别受体分子,在无脊椎动物的非特异性免疫系统中,扮演重要角色。
Lectins 作为一种模式识别受体(PRR),以细胞表面受体或者游离的可溶蛋白存在。
在识别异己和清除病原菌方面扮演重要角色。
他们识别并非特异性结合到细菌表面的糖残基,从而引发细菌的凝集。
Lectin因为不同的糖类识别结构域类型可以分为很多种。
其中C型凝集素是用来描述一种依赖钙离子的糖类结合蛋白。
C型凝集素通过典型的糖类识别结构域(CRD)与细菌表面糖残基结合并诱发一系列免疫应答。
关键词:中华绒螯蟹,先天免疫,C型凝集素ABSTRACTC-type lectins as one of pattern recognition receptors play great roles in recognizing and eliminating pathogens in innate immunity.In this study, a novel C-type lectin (EsLecD) was identified from Eriocheir sinensis. The cloning of full-length EsLeD cDNA were based on the initial expressed sequence tags (EST) isolated from a hepatopancreatic cDNA library .The full-length cDNA of EsLecD was 686bp with an open reading frame of 468 bp encoding a putative protein of 155 amino acids with a N-terminal signal peptide and a single carbohydrate-recognition domain (CRD). The mRNA transcripts of EsLecD was mainly detected in hepatopancreas but not in other tissues by Reverse transcription-PCR analysis and post LPS immune challenge, the mRNA expression level in hemocytes significantly up-regulated. The recombinant EsLecD(rEsLecD) protein can bind to some Gram-positive, Gram-negative bacteria and Yeast and Calcium (Ca2+) can increase the binding activity, but not essential. rEslecD may bind to pathogen with a wide range. The recombinant protein can inhibit the grouth of the microorganism we tested at absent of Ca2+. Our results showed rEsLecD agglutinated some microorganism in a Ca2+-dependent manner. Except for the binding activities, rEsLecD could induce the aggregation but does not happen in the absence of Ca2+. It has been shown that the rEsLecD could also stimulate hemocyte encapsulation. In conclusion, our study suggested that rEsLecD as a significant PRR have a part in recognizing invading pathogens in crabs and play a great role in innate immunity.Keywords:Eriocheir sinensis, innate immunity, C-type lectin目录论文摘要 (V)ABSTRACT ................................................................................................................. V I 第一章综述 (1)第一节甲壳动物动物免疫系统 (1)第二节C型凝集素简介 (5)第三节本研究的意义及技术路线 (12)第二章EsLecD基因的序列以及表达模式分析 (14)第一节EsLecD基因全长的克隆 (14)第二节EsLecD基因的序列分析 (20)第三节EsLecD表达模式分析 (24)第三章EsLecD的抗菌机制探讨 (28)第一节重组载体构建以及重组蛋白的表达和纯化 (28)第二节rEsLecD与细菌的结合以及钙离子依赖性分析 (35)第三节rEsLecD抑菌和杀菌活性的分析 (44)第四节rEsLecD凝集细菌活性分析 (46)第五节rEsLecD参与血细胞包裹作用的分析 (48)第四章总结及展望 (51)参考文献 (53)附录 (61)致谢 (62)第一章综述第一节无脊椎动物免疫系统免疫系统一般分为天然免疫(natural immunity)和获得性免疫(acquried immunity),或者被称为先天免疫(innate immunity)和适应性免疫(adaptive immunity)。
微生物培养基名称英汉对照-
微生物培养基名称英汉对照大肠杆菌显色培养基E.Coli Chromogenic Medium大肠菌群显色培养基Coliform Chromogenic Medium大肠杆菌/大肠菌群显色培养基E.Coli/Coliform Chromogenic Medium细菌总数显色培养基Total Genes Chromogenic MediumO157显色培养基O157 Chromogenic Medium沙门氏菌显色培养基Salmonella Chromogenic Medium李氏菌显色培养基Listera Chromogenic Medium金黄色葡萄球显色培养基Staphylococcus Chromogenic Medium霉菌和酵母菌显色培养基Mould and Yeast Chromogenic Medium弧菌显色培养基Vibrio Chromogenic Medium坂崎杆菌显色培养基Enterobacter sakazakii Chromogenic Medium平板计数琼脂〔PCA〕Plate Count Agar月桂基硫酸盐胰蛋白胨肉汤〔LST〕Lauryl Sulfate Tryptose Broth4-甲基伞形酮-D-葡萄糖醛酸苷〔MUG〕煌绿乳糖胆盐肉汤〔BGLB〕Brilliant Green Lactose Bile BroghEC 肉汤E.Coli Broth新生霉素A伊红美蓝琼脂(EMB)Eosin-Methylene Blue Agar营养肉汤(NB)Nutrient Broth营养琼脂(NA)Nutrient Agar乳糖胆盐发酵培养基Lactose Bile Broth乳糖复发酵培养基Lactose Broth去氧胆酸盐琼脂Desoxycholate Lactose AgarMR-VP培养基Methyl Red Voges Proskauer Broth 结晶紫中性红胆盐琼脂(VRBA) Violet Red Bile Agar西蒙氏枸橼酸盐琼脂Simmons Citrate Agar肠道菌计数琼脂(VRBDA)Violet Red Bile Dextrose Agar菌种储存培养基Strain Store Medium品红亚硫酸钠琼脂Fuchsin Basic Sodium Sulfite Agar 乳糖蛋白胨培养液Lactose Peptone BrothCary-Blair 氏运送培养基Cary-Blair Transport Medium山梨酸麦康凯琼脂基础Sorbitol Maconkey Agar Base噻孢霉素A1%亚碲酸钾溶液亮绿乳糖培养基Brilliant Green Lactose Medium肠道菌增菌肉汤(EE) Enterobacteria Enrichment Bro%) 胰蛋白胨大豆肉汤Trypticase (Tryptic) Soy Broth Baird-Parker琼脂基础Baird-Parker Agar Base亚碲酸盐卵黄增菌液Egg-Yolk Tellurite Emulsion胰蛋白胨大豆肉汤Trypticase (Tryptic) Soy Broth Baird-Parker琼脂基础Baird-Parker Agar Base亚碲酸盐卵黄增菌液Egg-Yolk Tellurite Emulsion兔血浆Freeze-Dried PlasmaDNA酶琼脂DNase Agar7.5%氯化钠肉汤7.5% Sodium Chloride Broth一般肉汤培养基Broth Medium亚碲酸钠肉汤培养基基础Sodium Tellurite Broth Base葡萄球菌增菌肉汤Staphylococcus Enrichment Broth葡萄球菌选择性琼脂Staphylococcus Selective AgarEEM培养基EEM medium甘露醇高盐琼脂Manitol Salt Agar肠毒素产毒培养基TMP琼脂培养基缓冲蛋白胨水〔BPW〕Buffered Peptone Water亚硒酸盐胱氨酸增菌液〔SC〕Selenite Cystine Broth四硫磺酸盐煌绿增菌液基础(TTB)Tetrathionate Broth Base胆硫乳琼脂〔DHL〕Deoxycholate Hydrogen Sulfide Lactose Agar 三糖铁琼脂〔TSI〕Triple Sugar Iron AgarSS 琼脂Salmonella Shigella Agar亚硫酸铋琼脂〔BS〕Bismuth Sulfite Agar亚利桑那菌琼脂〔SA〕Salmonella Arizona Agar氯化镁孔雀绿肉汤〔MM,RV Medium〕Rappaport-Vassiliadis MdeiumHE 琼脂〔HE〕Hekton Enteric Agar赖氨酸脱羧酶培养基Lysine-decarboxylase Test Broth尿素酶琼脂基础Urease Agar Base40%尿素水40%Urea WaterV-P 半固体琼脂Voges-Proskauer Semisolid Agar吲哚培养基Indole MediumKovacs氏靛基质试剂盒硝酸盐氰化钾培养基基础Nitrate(KCN) Broth Base丙二酸钠培养基Malonate Broth卫矛醇半固体琼脂Dulcitol Semisolid AgarGN 增菌液Gram Negative Enrichment BrothXLD 培养基Xylose Lysine Desoxycholate MediumWS 琼脂WS Salmonella Agar葡萄糖铵培养基Ammonium Dextrose Medium葡萄糖半固体培养基Dextrose Semisolid Medium动力-吲哚-尿素培养基基础(MIU) Motility Indol Urea Medium Base 亚硒酸盐增菌液(SF)Selenite Enrichment Medium醋酸铅培养基Lead Acetate MediumSIM培养基Hydrogen Sulfide Indole Motility Medium乳糖肉汤Lactose BrothEF-18 琼脂EF-18 Agar新生霉素碱性蛋白胨水Alkaline Peptone WaterTCBS琼脂Thiosulfate Citrate Bile Salts Sucrose Agar氯化钠多粘菌素B肉汤基础(SCPB)Sodium Chloride Polymyxin Broth Base多粘菌素B庆大霉素琼脂Gentamycin Agar四号琼脂基础No.4Agar Base我妻氏培养基基础Wagstsuma Agar Base60%/L氯化钠蛋白胨肉汤60%/L NaCl Peptone Water氯化钠三糖铁NaCl Triple Sugar Iron Agar胰胨大豆琼脂斜面〔TSA〕Trypcasein Soy Agar42℃生长培养基42℃growth MediumO/F培养基(HLGB)O/F Medium氯化钠结晶紫增菌液Sodium Chloride Violet purple Enrichment Broth 氯化钠蔗糖琼脂Sodium Chloride Sucrose Agar嗜盐菌选择性琼脂氯化钠血琼脂基础Sodium Chloride Blood Agar Base霍乱双糖铁琼脂(KIA)副溶血性弧菌琼脂副溶血性弧菌增菌液T1N1 琼脂T1N1 AgarT1N0 肉汤T1N0 BrothT1N3 肉汤T1N3 Broth精氨酸葡萄糖斜面琼脂Arginine Dextrose Agar精氨酸双水解酶试验用培养基(AD)mCPC 培养基mCPC MediummCPC培养基添加剂mCPC Medium Supplement察氏琼脂Czapek Dox Agar产毒培养基Toxin-Producing Medium马铃薯葡萄糖琼脂(PDA)Potato Dextrose Agar高盐察氏琼脂Salt Czapek Dox Agar沙氏琼脂培养基Sabouraud's Agar改良沙氏琼脂培养基Sabouraud's Agar,ModifiedCorn Meat Medium孟加拉红培养基Rose Bengal Medium菌种培养基Strain Medium(for B.Cereus)四环素检定琼脂Tetracyline Examination Agar亚硫酸盐琼脂Sulfite Agar亚硫酸铁琼脂Iron Sulfite Agar布氏肉汤Brucella Broth改良Skirrow氏琼脂基础Skirrow Agar Base,Modified改良Camp-BAP氏琼脂基础Camp-BAP Agar Base,ModifiedTTC 琼脂基础TTC Agar Base甘氨酸培养基Glycine Medium快速硫化氢试验琼脂H2S Test MediumDNA酶甲基绿琼脂基础DNase Agar Base with Methyl Green马尿酸钠培养基快速硫化氢(H2S)试验琼脂CCDA基础CCDA BaseCCDA添加剂CCDA SupplementCampy-Cefex 琼脂基础Campy-Cefex Agar BaseCampy-Cefex 添加剂Campy-Cefex Supplement甘露醇卵黄多粘菌素琼脂基础〔MYP〕Mannitol-Egg-Yolk-Polymyxin Agar Base 胰酪胨大豆多粘菌素肉汤基础Trypticase-Soy-Polymyxin Broth Base 改良V-P培养基Medium,Modified胰酪胨大豆羊血琼脂基础Trypticase Soy Sheep Blood Agar BaseCasein Agar酚红葡萄糖肉汤硝酸盐肉汤动力-硝盐培养基木糖-明胶培养基胰月示-亚硫酸盐-环丝氨酸琼脂基础(TSC)Tryptose Sulfite Cycloserine Agar Base D-环丝氨酸产芽孢肉汤Sporulation Broth亚硫酸盐-多粘菌素-磺胺嘧啶琼脂基础Sulfite-Polymyxin-Sulphadiazine Agar Base 多粘菌素B多价蛋白胨-酵母膏(PY) 培养基Poly Peptone Yeast Extract Medium疱肉培养基基础Cooked Meat Medium Base疱肉牛肉粒Dried Meat Particle液体硫乙醇酸盐培养基Thiolglycollate Medium(Agar-free)卵黄琼脂培养基基础Egg Yolk Agar Base动力-硝酸盐培养基含铁牛奶培养基葡萄糖肉浸液肉汤Dextrose Meat Infusion Broth匹克匹克氏肉汤基础APick's Broth BaseA肉浸液肉汤培养基Meat Infusion Broth叠氮钠葡萄糖肉汤Aziode Dextrose Broth乙基紫叠氮钠肉汤Ethyl Violet Aziode BrothKF链球菌琼脂KF Streptococcus AgarLIM培养基LIM MediumCIN-1I培养基基础Cepulodin Irgasan Novobiocin Agar改良Y培养基Agar,Modified改良磷酸盐缓冲液PSB Phosphate Saline Buffer,Modified 0.5%葡萄糖肉汤培养基0.5% Dextrose Broth溴甲酚紫葡萄糖蛋白胨水培养基Glucase Peptone Water Medium 改良番茄汁培养基Tomato Juice Agar,Modified改良MC培养基Chalmers Agar ,ModifiedMRS 琼脂基础MRS Agar BaseLBS 琼脂LBS agar胰酪胨大豆酵母浸膏肉汤(TSB-YE) Trypticase Soy-Yeast Extract Broth 萘啶酮酸吖啶黄素放线菌酮胰酪胨大豆酵母浸膏琼脂(TSA-YE) Trypticase Soy-Yeast Extract Agar 李氏菌选择性培养基基础(MMA) Modified Mcbride Agar Base复达欣糖发酵基础肉汤Bromcresol Purple Broth Base李氏菌增菌肉汤(LB1,LB2)基础Listeria Enrichment Broth Base萘啶酮酸萘啶酮酸吖啶黄素吖啶黄素七叶苷培养基Esculin Medium半固体动力培养基Motility Test Medium(Semisolid)牛津琼脂(OXA)基础Oxford Agar Base多粘菌素E放线菌酮溴甲酚紫葡萄糖肉汤Bromcresol Purple Dextrose Broth 酸性肉汤Acid Borth麦芽浸膏汤Malt Extract Broth锰盐营养琼脂Mn2+Nutrient Agar疱肉培养基基础Cooked Meat Medium Base卵黄琼脂基础Egg Yolk Agar Base疱肉牛肉粒Dried Meat ParticleUBA培养基UBA MediumNBB培养基NBB AgarMRS 琼脂基础MRS Agar BaseRaka-Ray 培养基Raka-Ray MediumSCDLP液体培养基Soya Casein Digest Lecithin Polysorbate Broth 卵磷脂吐温80营养琼脂Lecithin Tween 80 Nutrient Agar乙酰胺琼脂Acetamide Agar十六烷三甲基溴化铵琼脂Cetrimide Agar甘露醇发酵培养基Mannitol Medium明胶培养基基础Gelatin Medium Base绿脓菌素测定培养基King Medium A乳糖胆盐培养基Lactose Bile MediumTTC卵磷脂-吐温80-营养琼脂TTC Lecithin Tween80 Nutrient Agar液体硫乙醇酸盐培养基Thioglycollate Medium液体硫乙醇酸盐培养基〔不含琼脂〕Thioglycollate Medium (without Agar)真菌培养基Fungi MediumYPD琼脂Yeast Peptone Dextrose Agar抗生素检定培养基1号〔高PH〕Antibiotic Agar No.1抗生素检定培养基1号〔低PH〕Antibiotic Agar No.1抗生素检定培养基2号〔高PH〕Antibiotic Agar No.2抗生素检定培养基2号〔低PH〕Antibiotic Agar No.2抗生素检定培养基3号Antibiotic Agar No.3胆盐乳糖增菌液Bile Lactose Broth玫瑰红钠琼脂Rose Bengal Medium0.5%葡萄糖肉汤培养基Broth Medium肉汤琼脂培养基Broth Agar Medium一般琼脂斜面培养基(Ph8.0-8.2)甘露醇高盐琼脂Manitol Salt Agar酪胨琼脂Peptone from Casein Agar葡萄糖蛋白胨培养基Dextrose Peptone Medium抗生素检定培养基4号Antibiotic Agar No.4抗生素检定培养基6号Antibiotic Agar No.6抗生素检定培养基7号Antibiotic Agar No.7抗生素检定培养基8号Antibiotic Agar No.8卵黄高盐琼脂基础Egg-Yolk Salt Agar Base抗生素5号Antibiotic No.5MUG培养基MUG Medium真菌琼脂培养基Fungi Agar Medium磷酸盐葡萄糖胨水培养基Phosphate Glucose Peptone Water Medium 甲基红批示剂盒胰蛋白胨水培养基Peptone Water MediumKovacs氏靛基质试剂盒硝酸盐胨水培养基Nitrate Saline Peptone Water Medium 硝酸盐还原试剂盒抗生素检定培养基3号Antibiotic Agar No.3改良马丁液体培养基Martin Broth ,Modified改良马丁琼脂培养基Martin Agar Medium ,Modified庆大霉素琼脂Gentamycin AgarMH 肉汤〔MHB〕Mueller-Hinton BrothMH 琼脂〔MHA〕Mueller-Hinton Agar中国蓝琼脂China Blue Agar克氏双糖铁琼脂Kligler Iron Agar血液琼脂基础Blood Agar Base血液增菌培养基Blood Enrichment Medium氯化三苯四氮唑-沙保罗培养基TTC-Sabourand's Medium麦康凯琼脂Maconkey Agar麦康凯琼脂2号Maconkey Agar No.2麦康凯琼脂3号Maconkey Agar No.3碱性琼脂平板Alkaline Agar碱性胆盐琼脂Alkaline Bile Salt Agar胰膘肉汤基础Tryptose Broth Base豆粉琼脂〔血琼脂基础〕Blood Agar Base赫氏培养基赫氏增菌液溶血琼脂基础亚硫酸钠琼脂Sulfite Agar龙胆紫血液琼脂基础叠、红、碲、铜琼脂硫酸十二烷基钠琼脂改良罗氏培养基基础L-G medium Base,modified酸性L-G培养基基础碱性L-G培养基基础PNB〔对硝基苯甲酸〕TCH〔噻吩-2-羧酸酰肼〕戊烷脒多粘菌素B琼脂基础碳酸氢钠琼脂基础指示选择性培养基基础PLET 琼脂基础戊烷脒炭疽杆菌疫苗炭疽杆菌沉淀血清炭疽杆菌噬菌体炭疽杆菌诊断抗原青霉素敏感纸片印度墨汁碘伏〔液体〕溶菌酶美蓝〔亚甲基蓝〕水杨素醋酸盐琼脂Acetate Agar气单胞菌鉴别琼脂Aeromonas Differential Agar厌氧菌琼脂Anaerobic AgarAPT 琼脂APT Agar曲霉素琼脂基础(AFPA)腊样芽胞杆菌选择琼脂基础Bacilus Cereus Selective Agar Base 去氧胆酸盐枸椽酸盐乳糖蔗糖琼脂DCLS Agar去氧胆酸盐枸椽酸盐琼脂Desoxycholate Citrate AgarFraser 培养基Fraser MediumFraser 添加剂Fraser SupplementUVM培养基UVM MediumUVM 添加剂1UVM Supplement1UVM 添加剂2UVM Supplement2假单胞分开琼脂Pseudomonas Isolation Agar假单胞分开肉汤Pseudomonas Isolation Broth水琼脂培养基Water Agar肌醇测定培养基Inositol Assay Broth烟酸测定培养基Vitamin PP Assay Broth叶酸测定培养基Folic Acid Assay Medium泛酸测定培养基Pantothenic Acid Assay Medium 游离生物素测定培养基Free Biotin Assay Medium气单胞菌培养基基础Aeromonas Medium Base(Ryan) 气单胞菌培养基添加剂Ampicillin Selective Supplement LES Endo 琼脂Endo Agar,LES支原体培养基基础Mycoplasma Broth Base梭菌琼脂Clostridium Agar梭菌鉴别肉汤Clostridium Differential Broth梭菌选择琼脂Clostridium Selective Agar胰蛋白胨大豆琼脂Tryptose Soya Agar布氏菌选择性培养基Brucella Selective Medium细菌蛋白胨Peptone Bacterial胰蛋白胨Tryptone酪蛋白胨Peptone from Casein植物〔大豆〕蛋白胨Peptone from soy月示胨Proteose peptone多价蛋白胨Polypeptone特别蛋白胨Peptone Special牛心浸粉Beef Heart Infusion肝浸粉Liver Infusion牛肉浸粉Beef Extract Powder酵母浸粉Yeast Extract Powder酸水解酪蛋白Casein acid Hydrolysate 细菌琼脂粉Bacterial Agar牛胆盐Bile Salt三号胆盐No. 3 Bile Salt革兰氏染色液试剂盒Kovacs氏靛基质试剂盒甲基红指示剂盒V-P 试剂盒硝酸盐还原试剂盒1%亚碲酸钾溶液萋- 尼氏染色液Ziehl - neelsen金胺O染色液瑞氏染色液。
益生菌对阿尔茨海默病作用的研究进展
益生菌对阿尔茨海默病作用的研究进展发布时间:2021-12-14T06:08:15.523Z 来源:《中国结合医学杂志》2021年12期作者:宋鑫萍1,2,李盛钰2,金清1[导读] 阿尔茨海默病已成为威胁全球老年人生命健康的主要疾病之一,患者数量逐年攀升,其护理的经济成本高,给全球经济造成重大挑战。
近年来研究显示,益生菌在适量使用时作为有益于宿主健康的微生物,在防治阿尔茨海默病方面具有积极影响,其作用机制可能通过调节肠道菌群,影响神经免疫系统,调控神经活性物质以及代谢产物,通过肠-脑轴影响该病发生和发展。
宋鑫萍1,2,李盛钰2,金清11.延边大学农学院,吉林延吉 1330022.吉林省农业科学院农产品加工研究所,吉林长春 130033摘要:阿尔茨海默病已成为威胁全球老年人生命健康的主要疾病之一,患者数量逐年攀升,其护理的经济成本高,给全球经济造成重大挑战。
近年来研究显示,益生菌在适量使用时作为有益于宿主健康的微生物,在防治阿尔茨海默病方面具有积极影响,其作用机制可能通过调节肠道菌群,影响神经免疫系统,调控神经活性物质以及代谢产物,通过肠-脑轴影响该病发生和发展。
本文综述了近几年来国内外益生菌对阿尔茨海默病的作用进展,以及其预防和治疗阿尔茨海默病的潜在作用机制。
关键词:益生菌;阿尔茨海默病;肠道菌群;机制Recent Progress in Research on Probiotics Effect on Alzheimer’s DiseaseSONG Xinping1,2,LI Shengyu2,JI Qing1*(1.College of Agricultural, Yanbian University, Yanji 133002,China)(2.Institute of Agro-food Technology, Jilin Academy of Agricultural Sciences, Chanchun 130033, China)Abstract:Alzheimer’s disease has become one of the major diseases threatening the life and health of the global elderly. The number of patients is increasing year by year, and the economic cost of nursing is high, which poses a major challenge to the global economy. In recent years, studies have shown that probiotics, as microorganisms beneficial to the health of the host, have a positive impact on the prevention and treatment of Alzheimer’s disease. Its mechanism may be through regulating intestinal flora, affecting the nervous immune system, regulating the neuroactive substances and metabolites, and affecting the occurrence and development of the disease through thegut- brain axis. This paper reviews the progress of probiotics on Alzheimer’s disease at home and abroad in recent years, as well as its potential mechanism of prevention and treatment.Key words:probiotics; Alzheimer’s disease; gut microbiota; mechanism阿尔茨海默病(Alzheimer’s disease, AD),系中枢神经系统退行性疾病,属于老年期痴呆常见类型,临床特征主要包括:记忆力减退、认知功能障碍、行为改变、焦虑和抑郁等。
新型肿瘤学疗法!氧化铪纳米颗粒Nbtxr3治疗头颈癌(HNSCC):肿瘤部位激活,总生存期。。。
新型肿瘤学疗法!氧化铪纳⽶颗粒Nbtxr3治疗头颈癌(HNSCC):肿瘤部位激活,总⽣存期。
来源:本站原创 2021-10-28 02:20Nbtxr3具有⼀种物理作⽤机制(MoA),通过放疗激活,在所注射的肿瘤中诱导显著的肿瘤细胞死亡,随后触发适应性免疫反应和长期抗癌记忆。
头颈癌(图⽚来源:)2021年10⽉27⽇讯/⽣物⾕BIOON/ --Nanobiotix是⼀家处于后期临床阶段的⽣物技术公司,致⼒于开创颠覆性的、基于物理的治疗⽅法,为数百万患者带来⾰命性的治疗结果。
近⽇,该公司在2021年美国放射肿瘤学会(ASTRO)年会上公布了先导候选产品Nbtxr3治疗局部晚期头颈部鳞状细胞癌(LA-HNSCC)项⽬的新数据。
Nbtxr3是⼀种新型、潜在的⾸创(first-in-class)肿瘤学产品,由功能化氧化铪纳⽶颗粒组成,通过⼀次性瘤内注射给药,并通过放射激活。
该候选产品的物理作⽤机制(MoA)旨在通过放射激活时,在注射的肿瘤中诱导显著的肿瘤细胞死亡,随后触发适应性免疫反应和长期抗癌记忆。
考虑到物理MoA,Nanobiotix相信Nbtxr3可以扩展到任何可通过放疗治疗的实体肿瘤和任何治疗组合,特别是与免疫检查点抑制剂。
2020年2⽉,美国FDA已授予Nbtxr3快速通道资格(FTD):联⽤或不联⽤西妥昔单抗(cetuximab),⽤于治疗不适合铂类化疗的LA-HNSCC患者。
此次公布的数据来⾃⼀项多中⼼、开放标签、⾮随机、剂量递增和剂量扩展1期研究(Study102 Expansion),该研究正在评估Nbtxr3作为由放疗激活的单⼀药物,治疗不符合顺铂化疗资格且对西妥昔单抗不耐受的难治性⽼年和体弱LA-HNSCC患者的疗效和安全性。
数据显⽰,在可评估⼈群(n=41)中,中位总⽣存期(mOS)为18.1个⽉,中位⽆进展⽣存期(mPFS)为10.6个⽉。
⽽在整个⼈群(所有接受治疗的可评估和不可评估患者;n=54)中,mOS为14.1个⽉,mPFS为9.4个⽉。
细菌分类---1
细菌分类---1细菌分类1 酸杆菌门(Acidobacteria)1.1 酸杆菌纲(Acidobacteria)1.2 全噬菌纲(Holophagae)2 放线菌门(Actinobacteria)(⾼G+C⾰兰⽒阳性菌)2.1 放线菌纲(Actinobacteria)3 产⽔菌门(Aquificae)3.1 产⽔菌纲(Aquificae)4 拟杆菌门(Bacteroidetes)4.1 拟杆菌纲(Bacteroidetes)4.2 黄杆菌纲(Flavobacteria)4.3 鞘脂杆菌纲(Sphingobacteria)4.4 纲未定5 ⾐原体门(Chlamydiae)5.1 ⾐原体纲(Chlamydiae)6 绿菌门(Chlorobi)6.1 绿菌纲(Chlorobia)7 绿弯菌门(Chloroflexi)7.1 厌氧绳菌纲(Anaerolineae)7.2 暖绳菌纲(Caldilineae)7.3 绿弯菌纲(Chloroflexi)8 产⾦菌门(Chrysiogenetes)8.1 产⾦菌纲(Chrysiogenetes)9 蓝藻门(Cyanobacteria)9.1 蓝藻纲(Cyanobacteria)10 脱铁杆菌门(Deferribacteres)10.1 脱铁杆菌纲(Deferribacteres)11 异常球菌-栖热菌门(Deinococcus-Thermus)11.1 异常球菌纲(Deinococci)12 ⽹团菌门(Dictyoglomi)12.1 ⽹团菌纲(Dictyoglomi)13 纤维杆菌门(Fibrobacteres)13.1 纤维杆菌纲(Fibrobacteres)14 厚壁菌门(Firmicutes)(低G+C⾰兰⽒阳性菌)14.1 芽孢杆菌纲(Bacilli)14.2 梭菌纲(Clostridia)14.3 热⽯杆菌纲(Thermolithobacteria)15 梭杆菌门(Fusobacteria)15.1 梭杆菌纲(Fusobacteria)16 芽单胞菌门(Gemmatimonadetes)16.1 芽单胞菌纲(Gemmatimonadetes)17 黏胶球形菌门(Lentisphaerae)17.1 黏胶球形菌纲(Lentisphaerae)18 硝化螺旋菌门(Nitrospirae)18.1 硝化螺旋菌纲(Nitrospira)19 浮霉菌门(Planctomycetes)19.1 浮霉菌纲(Planctomycetacia)20 海绵杆菌门(Poribacteria)*21 变形菌门(Proteobacteria)21.1 α-变形菌纲(Alphaproteobacteria)21.2 β-变形菌纲(Betaproteobacteria)21.3 δ-变形菌纲(Deltaproteobacteria)21.4 ε-变形菌纲(Epsilonproteobacteria)21.5 γ-变形菌纲(Gammaproteobacteria)22 螺旋体门(Spirochaetes)22.1 螺旋体纲(Spirochaetes)23 柔膜菌门(Tenericutes)23.1 柔膜菌纲(Mollicutes)24 热脱硫杆菌门(Thermodesulfobacteria)24.1 热脱硫杆菌纲(Thermodesulfobacteria)25 热微菌门(Thermomicrobia)25.1 热微菌纲(Thermomicrobia)26 热袍菌门(Thermotogae)26.1 热袍菌纲(Thermotogae)27 疣微菌门(Verrucomicrobia)27.1 丰祐菌纲(Opitutae)27.2 疣微菌纲(Verrucomicrobiae)28 门未定28.1 纤线杆菌纲(Ktedonobacteria)酸杆菌门(Acidobacteria)酸杆菌纲(Acidobacteria)酸杆菌⽬(Acidobacteriales)酸杆菌科(Acidobacteriaceae)酸杆菌属(Acidobacterium) (Edaphobacter)(Terriglobus)全噬菌纲(Holophagae)⽯鳖杆菌⽬(Acanthopleuribacterales)⽯鳖杆菌科(Acanthopleuribacteraceae)⽯鳖杆菌属(Acanthopleuribacter)全噬菌⽬(Holophagales)全噬菌科(Holophagaceae)地发菌属(Geothrix)全噬菌属(Holophaga)放线菌门(Actinobacteria)(⾼G+C⾰兰⽒阳性菌)放线菌纲(Actinobacteria)酸微菌亚纲(Acidimicrobidae)酸微菌⽬(Acidimicrobiales)酸微菌亚⽬(Acidimicrobineae)酸微菌科(Acidimicrobiaceae)酸微菌属(Acidimicrobium)(Iamiaceae)(Iamia)放线菌亚纲(Actinobacteridae)放线菌⽬(Actinomycetales)放线菌亚⽬(Actinomycineae)放线菌科(Actinomycetaceae)放线棒菌属(Actinobaculum)放线菌属(Actinomyces)隐秘杆菌属(Arcanobacterium)(Falcivibrio)动弯杆菌属(Mobiluncus)(Varibaculum)(Actinopolysporineae) (Actinopolysporaceae) (Actinopolyspora)(Catenulisporineae)(Actinospicaceae)(Actinospica) (Catenulisporaceae) (Catenulispora)棒杆菌亚⽬(Corynebacterineae)棒杆菌科(Corynebacteriaceae) (Bacterionema)(Caseobacter)棒杆菌属(Corynebacterium) (Turicella)迪茨⽒菌科(Dietziaceae)迪茨⽒菌属(Dietzia)分枝杆菌科(Mycobacteriaceae)分枝杆菌属(Mycobacterium) (含结核杆菌)诺卡⽒菌科(Nocardiaceae)⼽登⽒菌属(Gordonia) (Micropolyspora)(Millisia)诺卡⽒菌属(Nocardia)红球菌属(Rhodococcus)斯科曼⽒菌属(Skermania) (Williamsia)(Smaragdicoccus) (Segniliparaceae)(Segniliparus)束村⽒菌科(Tsukamurellaceae)束村⽒菌属(Tsukamurella)弗兰克⽒菌亚⽬(Frankineae)酸热菌科(Acidothermaceae)酸热菌属(Acidothermus)弗兰克⽒菌科(Frankiaceae)弗兰克⽒菌属(Frankia)地嗜⽪菌科(Geodermatophilaceae)芽球菌属(Blastococcus)地嗜⽪菌属(Geodermatophilus) (Modestobacter) (Kineosporiaceae) (Cryptosporangium)(Kineococcus)(Kineosporia)(Nakamurellaceae)(Humicoccus)(Nakamurella)(Quadrisphaera)孢鱼菌科(Sporichthyaceae)孢鱼菌属(Sporichthya)糖霉菌亚⽬(Glycomycineae)糖霉菌科(Glycomycetaceae)糖霉菌属(Glycomyces) (Stackerbrandtia)微球菌亚⽬(Micrococcineae)获⼭⽒菌科(Beutenbergiaceae)获⼭⽒菌属(Beutenbergia)乔治菌属(Georgenia)萨勒河菌属(Salana)博⼽⾥亚湖菌科(Bogoriellaceae)博⼽⾥亚湖菌属(Bogoriella)短杆菌科(Brevibacteriaceae)短杆菌属(Brevibacterium)纤维素单胞菌科(Cellulomonadaceae)纤维素单胞菌属(Cellulomonas)厄⽒菌属(Oerskovia)(Tropheryma)(Dermabacteraceae) (Brachybacterium) (Dermabacter) (Dermacoccaceae) (Demetria) (Dermacoccus) (Kytococcus) (Dermatophilaceae) (Dermatophilus) (Kineosphaera) (Intrasporangiaceae) (Arsenicicoccus) (Humihabitans) (Intrasporangium) (Janibacter) (Knoellia)(Kribbia) (Lapillicoccus) (Ornithinicoccus) (Ornithinimicrobium) (Oryzihumus) (Serinicoccus) (Terrabacter) (Terracoccus) (Tetrasphaera) (Jonesiaceae) (Jonesia) (Microbacteriaceae) (Agreia) (Agrococcus) (Agromyces) (Aureobacterium) (Clavibacter) (Cryobacterium) (Curtobacterium) (Frigoribacterium) (Frondicola) (Gulosibacter) (Labedella) (Leifsonia) (Leucobacter) (Microbacterium) (Microcella) (Mycetocola) (Okibacterium) (Plantibacter) (Pseudoclavibacter) (Rathayibacter) (Rhodoglobus) (Salinibacterium) (Subtercola) (Yonghaparkia) (Zimmermannella)微球菌科(Micrococcaceae) (Acaricomes)节杆菌属(Arthrobacter) (Citricoccus) (Kocuria)微球菌属(Micrococcus) (Nesterenkonia) (Renibacterium)罗⽒菌属(Rothia)⼝腔球菌属(Stomatococcus)刘志恒菌属(Zhihengliuella) (Promicromonosporaceae) (Cellulosimicrobium) (Isoptericola) (Myceligenerans) (Promicromonospora) (Xylanibacterium) (Xylanimonas) (Rarobacteraceae) (Rarobacter) (Sanguibacteraceae)⾎杆菌属(Sanguibacter) (Yaniaceae)(Yania)科未定(Actinotalea)(Demequina) (Phycicoccus)(Ruania)微单孢菌亚⽬(Micromonosporineae)微单孢菌科(Micromonosporaceae) (Actinocatenispora) (Actinoplanes) (Amorphosporangium) (Ampullariella)(Asanoa)(Catellatospora) (Catenuloplanes) (Couchiolanes) (Dactylosporangium) (Krasilnikovia)(Longispora) (Luedemannella)微单孢菌属(Micromonospora) (Pilimelia) (Planopolyspora) (Polymorphospora) (Salinispora)(Spirilliplanes) (Verrucosispora) (Virgisporangium)丙酸杆菌亚⽬(Propionibacterineae) (Nocardioidaceae) (Actinopolymorpha) (Aeromicrobium) (Friedmanniella)(Hongia)(Kribbella)(Marmoricola)(Micropruina) (Nocardioides) (Pimelobacter) (Propionicicella) (Propionicimonas)丙酸杆菌科(Propionibacteriaceae)河⼝微菌属(Aestuariimicrobium) (Arachnia)(Brooklawnia) (Granulicoccus)江⽒菌属(Jiangella) (Luteococcus)(Microlunatus)丙酸杆菌属(Propionibacterium) (Propioniferax) (Propionimicrobium) (Tessaracocccus) (Pseudonocardineae) (Actinosynnemataceae) (Actinokineospora) (Actinosynnema) (Lechevalieria) (Lentzea) (Saccharothrix) (Umezawaea) (Pseudonocardiaceae) (Actinoalloteichus) (Actinobispora) (Amycolata) (Amycolatopsis) (Crossiella)(Faenia) (Goodfellowia) (Kibdelosporangium) (Kutzneria) (Prauserella) (Pseudoamycolata) (Pseudonocardia) (Saccharomonospora) (Saccharopolyspora) (Streptoalloteichus) (Thermobispora) (Thermocrispum)链霉菌亚⽬(Streptomycineae)链霉菌科(Sterptomycetaceae) (Actinopycnidium) (Actinosporangium) (Chainia) (Elytrosporangium)北⾥菌属(Kitasatoa)北⾥孢菌属(Kitasatospora) (Microellobosporia) (Streptacidiphilus)链霉菌属(Streptomyces) (Streptoverticillium) (Streptosporangineae) (Nocardiopsaceae) (Nocardiopsis) (Streptomonospora) (Thermobifida) (Streptosporangiaceae) (Acrocarpospora) (Herbidospora) (Microbispora) (Microtetraspora) (Nonomuraea) (Planobispora) (Planomonospora) (Planotetraspora) (Sphaerisporangium) (Streptosporangium) (Thermopolyspora) (Thermomonosporaceae)珊瑚状放线菌属(Actinocorallia)(Actinomadura) (Excellospora) (Spirillospora) (Thermomonospora)双歧杆菌⽬(Bifidobacteriales)双歧杆菌科(Bifidobacteriaceae) (Aeriscardovia) (Alloscardovia)双歧杆菌属(Bifidobacterium) (Gardnerella) (Metascardovia) (Parascardovia) (Scardovia)科未定(Coriobacteridae) (Coriobacteriales) (Coriobacterineae) (Coriobacteriaceae)奇异菌属(Atopobium) (Collinsella) (Coriobacterium) (Cryptobacterium) (Denitrobacterium) (Eggerthella)(Olsenella)(Slackia)红⾊杆菌亚纲(Rubrobacteridae)红⾊杆菌⽬(Rubrobacterales)红⾊杆菌亚⽬(Rubrobacterineae) (Conexibacteraceae) (Conexibacter) (Patulibacteraceae) (Patulibacter)红⾊杆菌科(Rubrobacteraceae)红⾊杆菌属(Rubrobacter) (Solirubrobacteraceae) (Solirubrobacter) (Thermoleophilaceae) (Thermoleophilum)球形杆菌亚纲(Sphaerobacteridae)球形杆菌⽬(Sphaerobacterales)球形杆菌亚⽬(Sphaerobacterineae)球形杆菌科(Sphaerobacteraceae)球形杆菌属(Sphaerobacter)产⽔菌门(Aquificae)产⽔菌纲(Aquificae)产⽔菌⽬(Aquificales)产⽔菌科(Aquificaceae)产⽔菌属(Aquifex) (Calderobacterium) (Hydrogenivirga) (Hydrogenobacter) (Hydrogenobaculum) (Thermocrinis)除硫杆菌科(Desulfurobacteriaceae) (Balnearium)除硫杆菌属(Desulfurobacterium)热弧菌属(Thermovibrio) (Hydrogenothermaceae) (Hydrogenothermus)(Persephonella)(Sulfurihydrogenibium)拟杆菌门(Bacteroidetes)拟杆菌纲(Bacteroidetes)拟杆菌⽬(Bacteroidales)拟杆菌科(Bacteroidaceae)(Acetomicrobium)(Anaerophaga)(Anaerorhabdus)拟杆菌属(Bacteroides)(Pontibacter)紫单胞菌科(Porphyromonadaceae)(Barnesiella)(Capsularis)(Dysgonomonas)(Hallella)(Odoribacter)(Oribaculum)(Paludibacter)(Parabacteroides)紫单胞菌属(Porphyromonas) (多译作“卟啉单胞菌”,但porphyro-应来源于希腊语“紫⾊”)(Proteiniphilum)(Tannerella)(Xylanibacter)普雷沃⽒菌科(Prevotellaceae)普雷沃⽒菌属(Prevotella) (或译作“普⽒菌”)理研菌科(Rikenellaceae)(Alistipes)(Alkaliflexus)(Marinilabilia)(Petrimonas)理研菌属(Rikenella) (注:Riken是⽇语“理化学研究所”简称)科未定(Acetofilamentum)(Acetothermus)黄杆菌纲(Flavobacteria)黄杆菌⽬(Flavobacteriales)蟑螂杆状体科(Blattabacteriaceae)蟑螂杆状体属(Blattabacterium)(Cryomorphaceae)(Algoriphagus)(Brumimicrobium)(Crocinitomix)(Cryomorpha)(Fluviicola)李时珍菌属(Lishizhenia)(Owenweeksia)黄杆菌科(Flavobacteriaceae)(Actibacter)(Aequorivita)(Algibacter)(Aquimarina)(Arenibacter)伯杰菌属(Bergeyella)(Bizionia)碳酸噬胞菌属(Capnocytophaga) (注:多译作“⼆氧化碳噬纤维菌属”)噬纤维素菌属(Cellulophaga)⾦黄杆菌属(Chryseobacterium)(Cloacibacterium)(Coenonia)(Costertonia) (Croceibacter)独岛菌属(Dokdonia)东海菌属(Donghaeana) (Elizabethkingia) (Empedobacter) (Epilithonimonas) (Flaviramulus)黄杆菌属(Flavobacterium) (Formosa)泥滩杆菌属(Gaetbulibacter)泥滩微菌属(Gaetbulimicrobium) (Galbibacter) (Gelidibacter)(Gillisia)(Gilvibacter)⾰兰菌属(Gramella) (Kaistella)(Kordia)(Krokinobacter) (Lacinutrix)列⽂虎克菌属(Leeuwenhoekiella) (Lutibacter)(Maribacter) (Mariniflexile) (Marixanthomonas) (Mesonia)(Muricauda)(Myroides)(Nonlabens)(Olleya) (Ornithobacterium) (Persicivirga)(Pibocella)极地杆菌属(Polaribacter)冷弯菌属(Psychroflexus) (Psychroserpens) (Riemerella) (Robiginitalea) (Salegentibacter) (Sandarakinotalea) (Sediminibacter) (Sediminicola)世宗菌属(Sejongia) (Stanierella) (Stenothermobacter) (Subsaxibacter) (Subsaximicrobium) (Tamlana) (Tenacibaculum) (Ulvibacter)(Vitellibacter) (Wautersiella) (Weeksella) (Winogradskyella)丽⽔菌属(Yeosuana) (Zeaxanthinibacter)周⽒菌属(Zhouia) (Zobellia)王祖农菌属(Zunongwangia)鞘脂杆菌纲(Sphingobacteria)鞘脂杆菌⽬(Sphingobacteriales)泉发菌科(Crenotrichaceae)(Balneola)(Chitinophaga)泉发菌属(Crenothrix)(Rhodothermus)(Salinibacter)(Terrimonas)(Toxothrix)(Flammeovirgaceae)(Flammeovirga)(Flexithrix)(Perexilibacter)(Persicobacter)(Rapidithrix)(Sediminitomix)(Thermonema)屈挠杆菌科(Flexibacteraceae)(Adhaeribacter)(Aquiflexum)(Arcicella)(Belliella)(Chimaereicella)(Cyclobacterium)噬胞菌属(Cytophaga) (注:⽬前多称此属为“噬纤维菌属”,此处依拉丁⽂)(Dyadobacter)(Echinicola)(Effluviibacter)(Emticicia)(Fabibacter)(Flectobacillus)屈挠杆菌属(Flexibacter)(Hongiella)(Hymenobacter)(Larkinella)(Leadbetterella)(Marinicola)(Meniscus)(Microscilla)(Niastella)(Persicitalea)(Reichenbachiella)(Rhodonellum)(Roseivirga)(Runella)(Spirosoma)⽣孢噬胞菌属(Sporocytophaga)腐螺旋菌科(Saprospiraceae)(Aureispira)(Haliscomenobacter)(Lewinella)腐螺旋菌属(Saprospira)鞘脂杆菌科(Sphingobacteriaceae)(Mucilaginibacter)(Olivibacter)(Parapedobacter)(Pedobacter)(Pseudosphingobacterium)鞘脂杆菌属(Sphingobacterium)科未定(Niabella)纲未定(Flavisolibacter)(Fulvivirga)(Prolixibacter)(Segetibacter)⾐原体门(Chlamydiae)⾐原体纲(Chlamydiae)⾐原体⽬(Chlamydiales)⾐原体科(Chlamydiaceae)⾐原体属(Chlamydia)嗜⾐体属(Chlamydophila)副⾐原体属(Parachlamydiaceae)新⾐原体属(Neochlamydia)副⾐原体属(Parachlamydia)芯卡体科(Simkaniaceae)芯卡体属(Simkania) (注:⼈名缩写简称,此处⽤⾳译)棍⾐原体属(Rhabdochlamydia)*华诊体科(Waddliaceae)华诊体属(Waddlia) (注:WADDL为“华盛顿动物病诊断实验室”缩写)绿菌门(Chlorobi)绿菌纲(Chlorobia)绿菌⽬(Chlorobiales)绿菌科(Chlorobiaceae)臂绿菌属(Ancalochloris)绿棒菌属(Chlorobaculum)绿菌属(Chlorobium)绿爬菌属(Chloroherpeton)暗⽹菌属(Pelodictyon)突柄绿菌属(Prosthecochloris)绿弯菌门(Chloroflexi)厌氧绳菌纲(Anaerolineae)厌氧绳菌⽬(Anaerolineales)厌氧绳菌科(Anaerolineaceae)厌氧绳菌属(Anaerolinea)(Bellilinea)纤绳菌属(Leptolinea)(Levilinea)长绳菌属(Longilinea)暖绳菌纲(Caldilineae)暖绳菌⽬(Caldilineales)暖绳菌科(Caldilineaceae)暖绳菌属(Caldilinea)绿弯菌纲(Chloroflexi)绿弯菌⽬(Chloroflexales)绿弯菌科(Chloroflexaceae)绿弯菌属(Chloroflexus)绿线菌属(Chloronema)太阳发菌属(Heliothrix)玫瑰弯菌属(Roseiflexus)颤绿菌科(Oscillochloridaceae)颤绿菌属(Oscillochloris)爬管菌⽬(Herpetosiphonales)爬管菌科(Herpetosiphonaceae)爬管菌属(Herpetosiphon)产⾦菌门(Chrysiogenetes)产⾦菌纲(Chrysiogenetes)产⾦菌⽬(Chrysiogenales)产⾦菌科(Chrysiogenaceae)产⾦菌属(Chrysiogenes)蓝藻门(Cyanobacteria)蓝藻纲(Cyanobacteria)注:⽬前有三套蓝藻分类系统,分别为NCBI、Bergey's⼿册及Cavalier-Smith(2002年,仅分⾄⽬)。
海绵动物和刺细胞动物
研究海绵动物和刺细胞动物的生态修复潜力,为 其在海洋生态保护中的应用提供科学依据。
挑战与机遇并存
采样困难
海绵动物和刺细胞动物多分布于深海等难以到达的区域,采样困难 ,限制了对其深入研究。
毒素安全问题
部分刺细胞动物毒素具有强烈毒性,研究过程中需加强安全防护措 施。
跨学科合作
海绵动物和刺细胞动物研究涉及生物学、化学、生态学等多个学科领 域,需要加强跨学科合作与交流,推动研究成果的转化应用。
生态环境
海绵动物广泛分布于各种海洋环境中,从浅海到深海、从热带到寒带都有它们的 踪迹。它们通常附着在岩石、贝壳、珊瑚等硬质基底上生长,有些种类还能在泥 沙中生活。
02
刺细胞动物概述
定义与分类
刺细胞动物定义
刺细胞动物是一类具有刺丝囊(cnidocytes)的海洋生物,属于刺胞动物门(Cnidaria)和栉水母动 物门(Ctenophora)。
主要分类
根据形态和生态特征,刺细胞动物可分为水螅虫纲(Hydrozoa)、钵水母纲(Scyphozoa)、珊瑚 虫纲(Anthozoa)和栉水母纲(Ctenophora)。
形态特征与多样性
形态特征
刺细胞动物身体柔软,呈辐射对 称或两侧对称,具有刺丝囊以进 行捕食和防御。多数种类具有触 手,且触手上布满刺细胞。
细胞动物的利用不会破坏生态平衡。
公众教育
03
加强公众对海洋生态系统和生物多样性保护的认识和教育,提
高公众的环保意识和参与度。
05
研究现状与未来展望
当前研究热点及成果
海绵动物基因组学研究
揭示海绵动物的进化地位、物种多样性和基因组特点。
刺细胞动物毒素研究
发现多种具有药用价值的刺细胞动物毒素,并研究其作用机制和应 用前景。
活化部分凝血活酶时间检测狼疮抗凝物的灵敏度及其相关性
·502·活化部分凝血活酶时间 (activated partial thrombo -plastin time,APTT ) 凝血试验是将待测血浆和接触凝血因子激活剂、磷脂、氯化钙混合,记录血浆凝固的时间,通常用于筛查内源性和共同凝血途径的凝血障碍。
狼疮抗凝物 (lupus anticoagulant,LA ) 是一种能与带负电荷的磷脂或磷脂蛋白复合物结合的免疫球蛋白,属于抗磷脂抗体 (antiphospholipid antibody,APL ),可干扰依赖磷脂的体外凝血反应[1],其机制为· 论著 ·活化部分凝血活酶时间检测狼疮抗凝物的灵敏度及其相关性张家红,王金行,夏楠,李花 (中国医科大学附属第一医院检验科,沈阳 110001) 摘要 目的 评估常规活化部分凝血活酶时间 (APTT ) 对改良的稀释蝰蛇毒时间 (DRVVT ) 法及硅凝固时间 (SCT ) 法检测狼疮抗凝物 (LA ) 的灵敏度及相关性。
方法 回顾性分析2018年12月至2020年9月于我院检测LA 阳性且同时检测了APTT 的386例样本的检测结果。
根据APTT 参考区间上限分为APTT 正常组 (APTT≤43.0 s ) 和APTT 异常组 (APTT>43.0 s )。
2组数据非正态分布以M (P 25~P 75) 表示,组间数据比较采用非参数检验,采用受试者工作特征 (ROC ) 曲线分析LA 预测APTT 异常时的临界值和灵敏度,采用Spearman 秩相关分析APTT 与LA 的相关性。
结果 386例LA 阳性样本中,APTT 正常177例 (45.9%),APTT 异常209例 (54.1%)。
APTT 异常组的DRVVT 标准化比值 (NR ) 及SCT -NR 显著高于APTT 正常组 (P < 0.01)。
APTT 对LA 的灵敏度:DRVVT -NR、SCT -NR 分别为1.39和1.83。
白杨素对离体培养致炎大鼠软骨细胞凋亡及内质网应激GRP78
白杨素对离体培养致炎大鼠软骨细胞凋亡及内质网应激GRP78/PERK/CHOP通路的影响*廖太阳,杨楠,张力,吴鹏,王培民△,丁亮△[南京中医药大学附属医院(江苏省中医院)骨伤科,江苏南京210029][摘要]目的:观察白杨素(CHR )对大鼠软骨细胞凋亡的影响,并探究其可能分子机制。
方法:提取大鼠软骨细胞,使用脂多糖(LPS )诱导体外骨关节炎模型,将细胞随机分为对照(control )组、LPS 组及CHR 处理组(处理浓度分别为1和5mg/L );采用CCK -8法测定不同条件下软骨细胞的活力;采用流式细胞术检测细胞凋亡情况;Hoechst 33342染色法观察凋亡细胞核变化;Western blot 检测各组细胞凋亡相关蛋白及内质网应激相关蛋白[葡萄糖调节蛋白78(GRP78)、转录激活因子6(ATF -6)、CCAAT/增强子结合蛋白同源蛋白(CHOP )、蛋白激酶R 样内质网激酶(PERK )、p -PERK 、真核起始因子2α(eIF2α)和p -eIF2α]的表达水平。
结果:CHR 浓度为1和5mg/L 时可显著提高LPS 致炎软骨细胞的活力(P <0.05),逆转细胞凋亡情况,上调Bcl -2的蛋白表达(P <0.05),抑制Bax 、cleaved caspase -3、caspase -9、GRP78、ATF -6和CHOP 的蛋白表达(P <0.05),降低p -PERK/PERK 和p -eIF2α/eIF2α比值(P <0.05),以CHR 高浓度组效果更显著(P <0.05)。
结论:白杨素减轻LPS 诱导的大鼠软骨细胞凋亡,其机制与抑制内质网应激GRP78/PERK/CHOP 信号通路的活化有关。
[关键词]白杨素;细胞凋亡;脂多糖;软骨细胞;内质网应激[中图分类号]R684.3;R363.2[文献标志码]Adoi :10.3969/j.issn.1000-4718.2022.12.011Chrysin attenuates lipopolysaccharide -induced apoptosis of rat chondro⁃cytes via GRP78/PERK/CHOP signaling pathwayLIAO Tai -yang ,YANG Nan ,ZHANG Li ,WU Peng ,WANG Pei -min △,DING Liang △(Department of Orthopaedics and Traumatology ,Affilliated Hospital of Nanjing University of Chinese Medicine &Jiangsu Province Hospital of Chinese Medicine ,Nanjing 210029,China.E -mail :wangpeimin@ ;dee 1987@ )[ABSTRACT ]AIM :To observe the effect of chrysin (CHR )on the apoptosis of rat chondrocytes ,and to explore its possible mechanism.METHODS :Rat chondrocytes were isolated and osteoarthritis model was induced by lipopoly‐saccharide (LPS ).The chondrocytes were randomly divided into control group ,LPS group ,and CHR treatment groups (1and 5mg/L ,respectively ).The viability of chondrocytes was determined by CCK -8assay.Flow cytometry was used to de‐tect the apoptosis.Hoechst 33342staining was used to observe the nuclear changes of apoptotic cells.The levels of apopto‐sis -related proteins and endoplasmic reticulum stress -related proteins ,glucose -regulated protein 78(GRP78),activating transcription factor -6(ATF -6),CCAAT/enhancer -binding protein homologous protein (CHOP ),protein kinase R -like en‐doplasmic reticulum kinase (PERK ),p -PERK ,eukaryotic initiation factor 2α(eIF2α)and p -eIF2α,were determined by Western blot.RESULTS :Treatment with CHR at both 1and 5mg/L significantly increased the viability of LPS -induced chondrocytes (P <0.05),reversed the cell apoptosis ,up -regulated the protein expression of Bcl -2(P <0.05),inhibited the protein expression of Bax ,cleaved caspase -3,caspase -9,GRP78,ATF -6and CHOP (P <0.05),and decreased the ratios of p -PERK/PERK and p -eIF2α/eIF2α(P <0.05).CONCLUSION :Chrysin attenuates LPS -induced apoptosis ofrat chondrocytes via GRP78/PERK/CHOP signaling pathway.[文章编号]1000-4718(2022)12-2197-08[收稿日期]2022-07-21[修回日期]2022-11-01*[基金项目]国家自然科学基金资助项目(No.82074460);江苏省中医院高峰学术人才项目(No.y2021rc02);江苏省中医药科技发展计划项目(No.MS2021016)△通讯作者王培民Tel :025-********;E -mail :wangpeimin@ ;丁亮Tel :139****5506;E -mail :dee1987@··2197[KEY WORDS]Chrysin;Apoptosis;Lipopolysaccharides;Chondrocytes;Endoplasmic reticulum stress软骨细胞是关节软骨中唯一的细胞类型,在细胞外基质的合成和更新过程中发挥至关重要的作用,并维持基质的完整。
番杏的营养价值
如对您有帮助,可购买打赏,谢谢
番杏的营养价值
导语:大家对番杏了解吗,特也叫夏菠菜,洋菠菜,它的营养成分很高,健康价值也特别高,番杏也可以用来当做蔬菜,它含有很丰富的钙,铁和其他的维
大家对番杏了解吗,特也叫夏菠菜,洋菠菜,它的营养成分很高,健康价值也特别高,番杏也可以用来当做蔬菜,它含有很丰富的钙,铁和其他的维生素,也能够用来用做中药,清热解毒的效果甚好,一些医书里关于番杏的记载也已经是很多的了,下面我们就来看看番杏的营养价值。
番杏在我们平时的生活中也应该是很常见的了,很多人应该都吃过吧,它的味道是很好的,营养价值也特别好,也可以用来当做蔬菜食用,对于番杏的营养价值,下面我们就一起来了解一下。
番杏,学名:
野生茶籽生长在连绵叠嶂的大别山腹地中,山茶花开于秋季,果实成熟于次年花开时节;历经秋、冬、春、夏、秋五季的云滋雾养,饱受日月精华和天地灵气。
茶树的茶果从开花到成熟,尽吸天然养分、健康价值极高,堪称人间奇果。
用此油凉拌菜口感非常好,没有油腻的感觉。
主要价值
可作蔬菜,含丰富的铁、钙、维生素A和各种维生素B;也可药用,清热解毒,祛风消肿,治肠炎、败血症、疔疮红肿、风热目赤。
全草:
功能主治
清热解毒,祛风消肿。
治肠炎,败血病,疔疮红肿,风热目赤。
①《福建民间草药》:祛风除热,消肿解毒。
生活中的小知识分享,对您有帮助可购买打赏。
stemcells英语解释
"Stem cells" refers to a special type of undifferentiated cell that has the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential to either remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell. There are two main types of stem cells: embryonic stem cells and adult stem cells. Embryonic stem cells can be found in embryos and have the potential to become any type of cell in the body, while adult stem cells are found in various tissues and are more limited in the types of cells they can become. Stem cells have the potential to revolutionize medicine and are the subject of much research and debate due to their unique properties and potential applications in treating a wide range of diseases and injuries.。
从蝎子到免疫疗法团队将自然毒素用于CAR T
从蝎子到免疫疗法团队将自然毒素用于CAR T按照今天在《科学》杂志上颁发的临床前研究,希望之城的科学家已经开发并测试了第一种使用氯毒素(CLTX)的嵌合抗原受体(CAR)T细胞疗法,该毒素是蝎毒的一种成分,可将T细胞定向到脑肿瘤细胞。
转化医学。
该机构还开放了使用该疗法的第一项人体临床试验。
CAR通常在其靶向域中掺入单克隆抗体序列,从而使CAR T细胞能够识别抗原并杀死肿瘤细胞。
相反,CLTX-CAR使用的是一种36氨基酸的肽序列,该序列首先从追猎者的蝎毒中分离出来,现在被工程化为CAR识别域。
据美国癌症协会称,胶质母细胞瘤(GBM)是最常见的脑肿瘤类型,也是最致命的人类癌症之一。
由于肿瘤扩散到整个大脑中,因此特别难以治疗。
为GBM开发包罗CAR T细胞在内的免疫疗法的努力还必需与这些肿瘤内的高度异质性相抗衡。
在这项研究中,希望之城的研究人员在来自一群患有GBM的患者的切除样本中使用了肿瘤细胞,以比力CLTX结合与目前正在研究的CAR T细胞靶抗原(包罗IL13Rα2,HER2和EGFR)的表达。
他们发现CLTX与更大比例的患者肿瘤以及这些肿瘤内的细胞结合。
CLTX结合包罗被认为是种子复发的GBM干细胞样细胞。
与这些不雅察结果一致,CLTX-CAR T细胞识别并杀死了大量的GBM细胞,而忽略了大脑和其他器官中的非肿瘤细胞。
该研究小组证明,在基于细胞的测定法和动物模型中,CLTX导向的CAR T细胞在选择性杀死人GBM细胞方面非常有效,而没有肿瘤外靶向和毒性。
希望之城的克里斯汀·布朗博士说:“掺入氯毒素的CAR扩大了CAR T细胞疗法可能靶向的实体瘤的人群,这对于那些难以治疗的癌症如胶质母细胞瘤患者特别需要。
免疫治疗遗产提供者网络教授,T细胞治疗研究实验室副主任。
“这是CAR T疗法的全新靶向策略,其CAR 融合了不同于其他CAR的识别结构。
”希望之城教授兼发育与干细胞生物学系主任Michael Barish博士发起了使用氯毒素靶向GBM细胞的CAR的开发。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Culturing Rat Cortical Stem Cells: Expansion using the Neurosphere SystemEx vivo expanded neural stem cells serve as excellent tools for researchers studying neural development and neurological disorders. Ready-to-use primary cortical stem cells, isolated from E14.5 Sprague-Dawley rats (Catalog # NSC001), can be grown in monolayer or as neurospheres as described here. These cells retain capacity formulti-lineage differentiation into astrocytes, neurons, and oligodendrocytes.Please read the protocol in its entirety before starting.Supplies RequiredReagents∙N-2 Plus Media Supplement (R&D Systems, Catalog # AR003)∙Recombinant human FGF basic (R&D Systems, Catalog # 233-FB/CF) ∙Recombinant human EGF (R&D Systems, Catalog # 236-EG)∙PBS∙DMEM/F12∙Glucose∙Glutamine∙NaHCO3∙Penicillin-Streptomycin 100x∙BSA, very low endotoxin∙Acetic acid∙Trypan blue∙Deionized (DI) waterMaterials∙6-well plates∙15 mL centrifuge tubes∙Pasteur pipettes∙Pipettes and pipette tips∙0.2 µm, sterile filter unitEquipment∙37° C and 5% CO2 incubator∙Centrifuge∙Hemocytometer∙MicroscopeReagent & Media PreparationNote: Sterile technique is required when handling the reagents.∙Completed NSC Base Media - Mix the components listed in the chart below with DI water to make 500 mL of Completed NSC Base Media.Adjust the pH to 7.2 ± 0.2. Sterile filter the solution using a0.2 µm filter unit and store in the dark at 2-8° C for up to 2 weeks.Component AmountDMEM/F12 6 gGlucose 0.775 gGlutamine 0.0365 gNaHCO3 0.845 gN-2 Plus Media Supplement 5 mL∙FGF basic Stock (1000x) - Add sterile 0.1% BSA in PBS to the Human FGF basic vial to make a 20 µg/mL stock. Aliquot and store at -20°C in a manual defrost freezer for up to 6 months. Avoid repeatedfreeze-thaw cycles.∙EGF Stock (1000x) - Add sterile 0.1% BSA in 10 mM acetic acid to the Human EGF vial to make a 20 µg/mL stock. Aliquot and store at -20° C in a manual defrost freezer for up to 6 months. Avoidrepeated freeze-thaw cycles.ProcedureI.Thawing Cryopreserved Rat Cortical Stem Cells (Review thefollowing section in detail before thawing the cells)1.Warm 30 mL of Completed NSC Base Media in a 37° C water bath.2.Add 20 mL of pre-warmed Completed Base NSC Media supplementedwith FGF basic (20 ng/mL) and EGF (20 ng/mL) to a 50 mL tube.Reserve the remaining 10 mL pre-warmed Completed Base NSCMedia for step #5.3.Remove the cryovial containing frozen rat cortical stem cellsfrom the liquid nitrogen. Using a 2 mL pipette, immediatelyadd 1 mL of fresh pre-warmed media to the vial by gentlypipetting up and down. As cells begin to thaw, transfer thethawed portion into the pre-warmed media in the 50 mL tube.Repeat this process with the warmed media until all of thecells have thawed.Note: Most of the frozen cells will be at the bottom of thecryovial.4.Centrifuge the cells at 200 x g for 5 minutes.5.Aspirate off 95% of the supernatant carefully and resuspendby gently pipetting the cell pellet up and down with 10 mLof Completed Base Media with growth factors.Note: Rapid resuspension of frozen cells in warmed mediaduring thawing is critical. Allowing cells to thaw slowly inthe DMSO will dramatically reduce viability. Around 90% cellviability is expected from the freshly thawed cells when theappropriate thawing procedure is followed.6.Seed cells at a density according to the appropriateexpansion protocol described below.II.Neurosphere Expansion (Figure 1)1.Seed approximately 1 x 105NSCs in 5 mL of Completed NSC BaseMedia supplemented with 20 ng/mL of EGF and 20 ng/mL of FGFbasic per well in a 6-well plate..2.Incubate the cells at 37° C and 5% CO23.Add fresh EGF (20 ng/mL) and FGF basic (20 ng/mL) each dayto the media. Every fourth day, based on the number ofneurospheres, replace the media according to the stepsdescribed below.a.Less than 50 neurospheres - Transfer the neurospheres,using a Pasteur pipette, directly into 2.5 mL ofCompleted NSC Base Media containing EGF (20 ng/mL) andFGF basic (20 ng/mL) in one well of a 6-well plate. DONOT DISCARD THE CONDITIONED Media. Add 2.5 mL of thisconditioned media to the well. When there are fewerneurospheres, conditioned media is required. Only halfof the media is replaced with fresh Completed NSC BaseMedia containing EGF (20 ng/mL) and FGF basic (20ng/mL).b.More than 50 neurospheres - Transfer the mediacontaining the neurospheres to a 15 mL tube. Centrifugefor 5 minutes at 100 x g and remove the media. Gentlyresuspend the pellet using a small quantity of freshCompleted NSC Base Media containing EGF (20 ng/mL) andFGF basic (20 ng/mL). Add the neurosphere suspensionto 5 mL of fresh Completed Base Media containing EGF(20 ng/mL) and FGF basic (20 ng/mL) in one well of a6-well plate.4.Pass the cells according to the procedure described below at5-7 days, or when the neurospheres have a dark clump insideor ruffling on the outside of the neurosphere.Figure 1III.Passaging Neurospheres1.Transfer the media containing the floating neurospheres toa 15 mL tube. DO NOT DISLODGE ATTACHED NEUROSPHERES FORPASSAGE.2.Centrifuge for 5 minutes at 100 x g.3.Partially dissociate the neurospheres by pipetting up anddown 20 times with a P200 pipette, being careful not to createbubbles in the suspension.4.At passages 1 and 2 the cells should be split 1:1. Afterpassage 2 the cells can be split 1:2.。